Annotation Detail for NQO1
Basic Information Top
| Gene Symbol: | NQO1 ( DHQU,DIA4,DTD,NMOR1,NMORI,QR1 ) |
|---|---|
| Gene Full Name: | NAD(P)H dehydrogenase, quinone 1 |
| Band: | 16q22.1 |
| Quick Links | Entrez ID:1728; OMIM: 125860; Uniprot ID:NQO1_HUMAN; ENSEMBL ID: ENSG00000181019; HGNC ID: 2874 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| Metabolism of amino acids and derivatives |
| No data |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| 500789 | Regulation of ornithine decarboxylase (ODC) |
| No data |
| No data |
| Desease Name |
|---|
| cognitive function |
| Parkinson's disease |
| leukemia, myeloid |
| colorectal cancer |
| CARDIOVASCULAR |
| Alzheimer's disease |
| CANCER |
| PHARMACOGENOMIC |
| nasopharyngeal cancer |
| benzene toxicity |
| bladder cancer |
| esophageal cancer |
| esophageal squamous cell carcinoma |
| breast cancer |
| adenocarcinoma of the upper gastrointestinal tract. |
| NEUROLOGICAL |
| METABOLIC |
| leukemia, myelodysplastic (TRLIMDS) |
| decreased lung cancer risk |
| lung cancer |
| urolithiasis |
| leukemia |
| diabetes, type 2 |
| Barrett esophagus esophageal cancer |
| esophageal cancer and gastric cardiac carcinoma |
| cytogenetic studies |
| urothelial cancer |
| No data |
| Desease Name |
|---|
| Leukemia, post-chemotherapy, susceptibility to |
| Breast cancer, poor survival after chemotherapy for |
| Benzene toxicity, susceptibility to |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C009947 | 1,2,4-trichlorobenzene | NQO1 protein affects the susceptibility to 1,2,4-trichlorobenzene | affects response to substance | 10092053 |
| C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NQO1 mRNA | increases expression | 19371629 18617210 |
| C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | Acetaminophen promotes the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 19371629 |
| C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | NFE2L2 protein affects the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NQO1 mRNA] | affects reaction|increases expression | 19371629 |
| C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | NFE2L2 protein affects the reaction [[Acetaminophen co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in increased expression of NQO1 mRNA] | affects cotreatment|affects reaction|increases expression | 19371629 |
| C112765 | 17-(allylamino)-17-demethoxygeldanamycin | NQO1 protein results in increased susceptibility to 17-(allylamino)-17-demethoxygeldanamycin | increases response to substance | 10564678 |
| C515135 | 17-amino-17-demethoxygeldanamycin -C2-galactose | NQO1 protein results in increased reduction of 17-amino-17-demethoxygeldanamycin -C2-galactose | increases reduction | 16825487 |
| C448659 | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin | 5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione inhibits the reaction [NQO1 protein results in increased reduction of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin] | decreases reaction|increases reduction | 16825487 |
| C448659 | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin | NQO1 protein results in increased reduction of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin | increases reduction | 16825487 |
| C055903 | 1-cyano-2-hydroxy-3-butene | 1-cyano-2-hydroxy-3-butene results in increased activity of NQO1 protein | increases activity | 11446830 |
| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of NQO1 mRNA | increases expression | 19933214 |
| C014211 | 2,3,7,8-tetrachlorodibenzofuran | 2,3,7,8-tetrachlorodibenzofuran affects the expression of NQO1 mRNA | affects expression | 18343893 |
| C010914 | 2,4-diaminotoluene | 2,4-diaminotoluene results in increased expression of NQO1 mRNA | increases expression | 20713471 |
| C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of NQO1 mRNA | affects expression | 21346803 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [DPP3 protein results in increased expression of NQO1 protein] | decreases reaction|increases expression | 17360324 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [erucin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15896333 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SQSTM1 protein results in increased expression of NQO1 protein] | decreases reaction|increases expression | 17360324 |
| C117776 | 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone | NQO1 protein results in increased metabolism of and results in increased susceptibility to 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone | increases metabolic processing|increases response to substance | 9865924 |
| C117776 | 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone | NQO1 protein results in increased reduction of 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone | increases reduction | 17256129 |
| C117776 | 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone | NQO1 protein results in increased reduction of and results in increased activity of 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone | increases activity|increases reduction | 17015278 |
| C073715 | 2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone | NQO1 protein results in increased metabolism of and results in increased susceptibility to 2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone | increases metabolic processing|increases response to substance | 9865924 |
| C073715 | 2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone | NQO1 protein results in increased metabolism of 2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone | increases metabolic processing | 7620217 |
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of NQO1 mRNA | affects expression | 21346803 |
| C035208 | 2-amino-4,6-dinitrotoluene | 2-amino-4,6-dinitrotoluene affects the expression of NQO1 mRNA | affects expression | 21346803 |
| C003898 | 2-anisidine | 2-anisidine results in increased expression of NQO1 | increases expression | 11409192 |
| C116817 | 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid | 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid results in increased activity of NQO1 protein | increases activity | 18838692 |
| C005328 | 2-nitroanisole | 2-nitroanisole results in increased expression of NQO1 | increases expression | 11409192 |
| C019499 | 2-nitrofluorene | 2-nitrofluorene results in increased expression of NQO1 mRNA | increases expression | 14600272 15890375 |
| C476441 | 2-oxoselenazolidine-4-carboxylic acid | 2-oxoselenazolidine-4-carboxylic acid results in increased expression of NQO1 mRNA | increases expression | 16451816 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased activity of NQO1 protein | increases activity | 9029048 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of NQO1 mRNA | increases expression | 9029048 19033392 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased activity of NQO1 protein | increases activity | 15627257 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of NQO1 mRNA | increases expression | 19276070 14510636 15627257 16014739 11163336 |
| C018855 | 2-tert-butylhydroquinone | AG-879 inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 11163336 |
| C018855 | 2-tert-butylhydroquinone | Cycloheximide inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 14510636 |
| C018855 | 2-tert-butylhydroquinone | NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] | affects reaction|increases expression | 19276070 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased activity of NQO1 protein | increases activity | 16600132 |
| C016392 | 3,3'-diindolylmethane | 3,3'-diindolylmethane results in increased expression of NQO1 mRNA | increases expression | 15672752 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of NQO1 protein | increases activity | 16219370 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | Estradiol inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased activity of NQO1 protein] | decreases reaction|increases activity | 16219370 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NQO1 mRNA | increases expression | 18042819 17627975 |
| C527796 | 3-morpholinopropyl isothiocyanate | 3-morpholinopropyl isothiocyanate results in increased expression of NQO1 mRNA | increases expression | 20498004 |
| C117220 | 3-nitrobenzanthrone | NQO1 protein results in increased activity of 3-nitrobenzanthrone | increases activity | 15805261 |
| C035207 | 4-amino-2,6-dinitrotoluene | 4-amino-2,6-dinitrotoluene affects the expression of NQO1 mRNA | affects expression | 21346803 |
| C117304 | 4'-bromoflavone | 4'-bromoflavone results in increased activity of NQO1 protein | increases activity | 17876041 |
| C117304 | 4'-bromoflavone | 4'-bromoflavone results in increased activity of NQO1 protein | increases activity | 17876041 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NQO1 mRNA | increases expression | 14600272 15890375 |
| C029728 | 4-phenylenediamine | 4-phenylenediamine results in increased expression of NQO1 mRNA | increases expression | 19033392 16314067 |
| C100099 | 5-(1-aziridinyl)-2,4-dinitrobenzamide | NQO1 gene mutant form results in increased reduction of 5-(1-aziridinyl)-2,4-dinitrobenzamide | increases reduction | 11361019 |
| C100099 | 5-(1-aziridinyl)-2,4-dinitrobenzamide | NQO1 protein results in increased reduction of 5-(1-aziridinyl)-2,4-dinitrobenzamide | increases reduction | 11361019 |
| C100099 | 5-(1-aziridinyl)-2,4-dinitrobenzamide | NQO1 protein results in increased reduction of 5-(1-aziridinyl)-2,4-dinitrobenzamide | increases reduction | 11361019 |
| C444919 | 5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione | 5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione inhibits the reaction [NQO1 protein results in increased reduction of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin] | decreases reaction|increases reduction | 16825487 |
| C444919 | 5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione | 5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione results in decreased activity of NQO1 protein | decreases activity | 15896341 |
| C111984 | 6-methylsulfinylhexyl isothiocyanate | 6-methylsulfinylhexyl isothiocyanate results in increased activity of NQO1 protein | increases activity | 11706044 |
| C117298 | 7,8-benzoquinoline | 7,8-benzoquinoline results in increased activity of NQO1 protein | increases activity | 9176741 |
| D000082 | Acetaminophen | Acetaminophen results in increased activity of NQO1 protein | increases activity | 16610002 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of NQO1 protein | increases expression | 16610002 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of NQO1 mRNA | affects expression | 17562736 |
| D000082 | Acetaminophen | Acetaminophen promotes the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 19371629 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of NQO1 mRNA | increases expression | 19371629 15496496 12540782 17935745 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of NQO1 protein | increases expression | 17935745 |
| D000082 | Acetaminophen | NFE2L2 protein affects the reaction [[Acetaminophen co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in increased expression of NQO1 mRNA] | affects cotreatment|affects reaction|increases expression | 19371629 |
| D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of NQO1 mRNA] | affects reaction|increases expression | 19371629 17935745 |
| D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of NQO1 protein] | affects reaction|increases expression | 17935745 |
| D000082 | Acetaminophen | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 12540782 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of NQO1 mRNA | increases expression | 17202762 15120968 15976192 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 19033392 |
| D000111 | Acetylcysteine | [Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]] which results in decreased expression of NQO1 mRNA | decreases expression|decreases reaction|increases expression | 15044633 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15044633 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein] | decreases reaction|increases expression | 15044633 |
| D000171 | Acrolein | Acrolein results in increased expression of NQO1 mRNA | increases expression | 12084617 |
| D000171 | Acrolein | Acrolein results in increased expression of NQO1 mRNA | increases expression | 12763045 |
| D000181 | Acrylonitrile | Acrylonitrile results in increased activity of NQO1 protein | increases activity | 9029048 |
| D000181 | Acrylonitrile | Acrylonitrile results in increased expression of NQO1 mRNA | increases expression | 9029048 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of NQO1 mRNA | increases expression | 15890375 14600272 |
| C081020 | AG-879 | AG-879 inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 11163336 |
| C081020 | AG-879 | AG-879 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 11163336 |
| C038491 | allyl sulfide | allyl sulfide results in increased expression of NQO1 mRNA | increases expression | 17627975 |
| C040534 | alpha-hexachlorocyclohexane | alpha-hexachlorocyclohexane results in increased expression of NQO1 mRNA | increases expression | 16940010 17785943 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in increased activity of NQO1 protein | increases activity | 16906435 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in increased expression of NQO1 mRNA | increases expression | 17069994 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of NQO1 mRNA | affects expression | 16483693 |
| C019257 | angelica lactone | angelica lactone results in increased expression of NQO1 protein | increases expression | 11309284 |
| C091696 | antimony oxide | antimony oxide results in increased activity of NQO1 protein | increases activity | 9029048 |
| C091696 | antimony oxide | antimony oxide results in increased expression of NQO1 mRNA | increases expression | 9029048 |
| C060817 | apaziquone | NQO1 protein results in increased susceptibility to apaziquone | increases response to substance | 10910079 |
| C060817 | apaziquone | NQO1 protein results in increased metabolism of apaziquone | increases metabolic processing | 7620217 |
| D001149 | Arsenates | Arsenates results in increased expression of NQO1 mRNA | increases expression | 15345372 |
| D001151 | Arsenic | Arsenic results in increased expression of NQO1 mRNA | increases expression | 19945496 |
| D001151 | Arsenic | Arsenic promotes the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D001151 | Arsenic | Arsenic promotes the reaction [Methylcholanthrene results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D001151 | Arsenic | Arsenic promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D001151 | Arsenic | Arsenic results in increased activity of NQO1 protein | increases activity | 15337587 |
| D001151 | Arsenic | Arsenic results in increased expression of NQO1 mRNA | increases expression | 15337587 |
| D001151 | Arsenic | Arsenic results in increased expression of NQO1 protein | increases expression | 19786557 |
| C050510 | arsenic trichloride | arsenic trichloride results in increased expression of NQO1 mRNA | increases expression | 19276070 |
| C050510 | arsenic trichloride | NFE2L2 protein affects the reaction [arsenic trichloride results in increased expression of NQO1 mRNA] | affects reaction|increases expression | 19276070 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of NQO1 mRNA | increases expression | 19417148 |
| C015001 | arsenite | arsenite affects the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | affects reaction|increases activity | 18474416 |
| C015001 | arsenite | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 15894712 |
| C015001 | arsenite | arsenite promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 18474416 |
| C015001 | arsenite | arsenite results in increased activity of NQO1 protein | increases activity | 18474416 |
| C015001 | arsenite | arsenite results in increased degradation of NQO1 mRNA | increases degradation | 18474416 |
| C015001 | arsenite | arsenite results in increased expression of NQO1 mRNA | increases expression | 18474416 15345372 15894712 |
| C015001 | arsenite | Cycloheximide inhibits the reaction [arsenite results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 18474416 |
| D001205 | Ascorbic Acid | Ascorbic Acid promotes the reaction [sodium arsenite results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 16517059 |
| D001374 | Azacitidine | [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 17682057 |
| D001374 | Azacitidine | Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 17682057 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in increased activity of NQO1 protein | increases activity | 9029048 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in increased expression of NQO1 mRNA | increases expression | 9029048 |
| D001554 | Benzene | GSTM1 gene polymorphism affects the reaction [GSTT1 gene polymorphism affects the reaction [NQO1 gene SNP results in increased susceptibility to Benzene]] | affects reaction|increases response to substance | 17178637 |
| D001554 | Benzene | NQO1 gene polymorphism affects the susceptibility to Benzene | affects response to substance | 15256146 15591089 15226677 |
| D001554 | Benzene | NQO1 gene polymorphism results in increased susceptibility to Benzene | increases response to substance | 15226677 15727169 15935822 18214807 |
| D001554 | Benzene | NQO1 gene SNP results in increased susceptibility to Benzene | increases response to substance | 17178637 15576619 15748501 14694720 |
| D001554 | Benzene | NQO1 protein affects the metabolism of Benzene | affects metabolic processing | 15226677 |
| D001554 | Benzene | NQO1 protein affects the susceptibility to Benzene | affects response to substance | 12460800 11882782 |
| D001554 | Benzene | NQO1 protein results in increased metabolism of Benzene | increases metabolic processing | 17885617 |
| D001554 | Benzene | NQO1 gene mutant form results in increased susceptibility to Benzene | increases response to substance | 15935811 |
| D001554 | Benzene | NQO1 protein affects the susceptibility to Benzene | affects response to substance | 12615705 |
| D001554 | Benzene | Benzene affects the expression of NQO1 mRNA | affects expression | 15878777 |
| C018003 | benzo(a)pyrene-3,6-quinone | benzo(a)pyrene-3,6-quinone results in increased expression of NQO1 mRNA | increases expression | 11008122 |
| C018003 | benzo(a)pyrene-3,6-quinone | benzo(a)pyrene-3,6-quinone results in increased expression of NQO1 mRNA | increases expression | 11008122 |
| C017228 | benzo(a)pyrene 7,8-dihydrodiol | benzo(a)pyrene 7,8-dihydrodiol results in increased expression of NQO1 mRNA | increases expression | 11008122 |
| C017228 | benzo(a)pyrene 7,8-dihydrodiol | benzo(a)pyrene 7,8-dihydrodiol results in increased expression of NQO1 mRNA | increases expression | 11008122 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased activity of NQO1 protein | increases activity | 15337587 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of NQO1 mRNA | increases expression | 15337587 17627975 14510636 |
| D019324 | beta-Naphthoflavone | Cadmium inhibits the reaction [beta-Naphthoflavone results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15337587 |
| D019324 | beta-Naphthoflavone | Chromium inhibits the reaction [beta-Naphthoflavone results in increased activity of NQO1 protein] | decreases reaction|increases activity | 15337587 |
| D019324 | beta-Naphthoflavone | Chromium inhibits the reaction [beta-Naphthoflavone results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15337587 |
| D019324 | beta-Naphthoflavone | Lipopolysaccharides inhibits the reaction [beta-Naphthoflavone results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15627257 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased activity of NQO1 protein | increases activity | 15871734 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased activity of NQO1 protein | increases activity | 16906435 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of NQO1 mRNA | increases expression | 21203749 17069994 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 21295105 20045035 18164116 |
| C039108 | benzo(f)quinoline | benzo(f)quinoline results in increased activity of NQO1 protein | increases activity | 9176741 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene metabolite results in increased expression of NQO1 mRNA | increases expression | 11008122 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NQO1 mRNA | increases expression | 15808406 20106945 15735009 11008122 19152381 20498004 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NQO1 protein | increases expression | 20498004 |
| D001564 | Benzo(a)pyrene | chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 19152381 |
| D001564 | Benzo(a)pyrene | Arsenic promotes the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D001564 | Benzo(a)pyrene | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 15894712 |
| D001564 | Benzo(a)pyrene | [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 17682057 |
| D001564 | Benzo(a)pyrene | Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 17682057 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of NQO1 protein | increases activity | 15337587 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NQO1 mRNA | increases expression | 15337587 17682057 15894712 20713471 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NQO1 protein | increases expression | 21042282 |
| D001564 | Benzo(a)pyrene | Butyrates inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 17682057 |
| D001564 | Benzo(a)pyrene | Cadmium promotes the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D001564 | Benzo(a)pyrene | Chromium inhibits the reaction [Benzo(a)pyrene results in increased activity of NQO1 protein] | decreases reaction|increases activity | 15337587 |
| D001564 | Benzo(a)pyrene | Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 17682057 15337587 |
| D001564 | Benzo(a)pyrene | NQO1 protein affects the reaction [Benzo(a)pyrene results in increased stability of TRP63 protein] | affects reaction|increases stability | 21042282 |
| D001564 | Benzo(a)pyrene | NQO1 protein affects the susceptibility to Benzo(a)pyrene | affects response to substance | 21042282 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of NQO1 protein | increases activity | 15871734 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of NQO1 protein | increases activity | 12088631 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene metabolite results in increased expression of NQO1 mRNA | increases expression | 11008122 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of NQO1 protein | increases activity | 19497421 16906435 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NQO1 mRNA | increases expression | 19497421 11008122 |
| D001564 | Benzo(a)pyrene | Dicumarol inhibits the reaction [Benzo(a)pyrene results in increased activity of NQO1 protein] | decreases reaction|increases activity | 19497421 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NQO1 mRNA | increases expression | 17944540 |
| C004532 | benzoquinone | benzoquinone results in increased expression of NQO1 mRNA | increases expression | 8652659 |
| D016227 | Benzoquinones | Benzoquinones results in increased activity of NQO1 protein | increases activity | 3127038 |
| D016227 | Benzoquinones | NQO1 protein affects the susceptibility to Benzoquinones | affects response to substance | 3127038 |
| C031403 | benzyl isothiocyanate | benzyl isothiocyanate results in increased activity of NQO1 protein | increases activity | 18838692 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Lead results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 16243960 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Mercury results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 16243960 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 16243960 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide promotes the reaction [Copper results in decreased expression of NQO1 mRNA]] | decreases expression|decreases reaction|increases reaction | 16243960 |
| C518535 | bis(2-hydroxybenzylidene)acetone | bis(2-hydroxybenzylidene)acetone results in increased activity of NQO1 protein | increases activity | 18838692 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane results in increased expression of NQO1 mRNA | increases expression | 19188863 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane results in increased expression of NQO1 protein | increases expression | 19188863 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane results in increased expression of NQO1 mRNA | increases expression | 17535857 |
| C002791 | bismuth tripotassium dicitrate | bismuth tripotassium dicitrate results in increased expression of NQO1 mRNA | increases expression | 15912405 |
| C032036 | bromobenzene | NQO1 protein affects the susceptibility to bromobenzene | affects response to substance | 10092053 |
| C032036 | bromobenzene | bromobenzene results in increased expression of NQO1 mRNA | increases expression | 15976192 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine results in increased activity of NQO1 protein | increases activity | 16906435 |
| D019328 | Buthionine Sulfoximine | Methylcholanthrene promotes the reaction [Buthionine Sulfoximine results in increased activity of NQO1 protein] | increases activity|increases reaction | 16906435 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased expression of NQO1 mRNA | increases expression | 18227147 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased activity of NQO1 protein | increases activity | 10092053 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased expression of NQO1 mRNA | increases expression | 17627975 15919853 19144771 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased expression of NQO1 protein | increases expression | 11309284 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased activity of NQO1 protein | increases activity | 16045903 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in increased activity of NQO1 protein | increases activity | 12659720 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in increased activity of NQO1 protein | increases activity | 16045903 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in increased expression of NQO1 mRNA | increases expression | 20308224 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of NQO1 mRNA | increases expression | 12414654 |
| D002087 | Butyrates | [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 17682057 |
| D002087 | Butyrates | Butyrates inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 17682057 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of NQO1 mRNA | increases expression | 15345372 |
| D002104 | Cadmium | Cadmium results in increased activity of NQO1 protein | increases activity | 21172416 |
| D002104 | Cadmium | Cadmium results in increased expression of NQO1 mRNA | increases expression | 21172416 |
| D002104 | Cadmium | Cadmium results in increased expression of NQO1 protein | increases expression | 21172416 |
| D002104 | Cadmium | Cadmium inhibits the reaction [beta-Naphthoflavone results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15337587 |
| D002104 | Cadmium | Cadmium promotes the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D002104 | Cadmium | Cadmium promotes the reaction [Methylcholanthrene results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D002104 | Cadmium | Cadmium promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | increases activity|increases reaction | 18474416 |
| D002104 | Cadmium | Cadmium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 18474416 |
| D002104 | Cadmium | Cadmium results in increased activity of NQO1 protein | increases activity | 15337587 18474416 |
| D002104 | Cadmium | Cadmium results in increased degradation of NQO1 mRNA | increases degradation | 18474416 |
| D002104 | Cadmium | Cadmium results in increased expression of NQO1 mRNA | increases expression | 15337587 16517059 18474416 |
| D002104 | Cadmium | Cycloheximide inhibits the reaction [Cadmium results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 18474416 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased activity of NQO1 protein | increases activity | 18838692 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of NQO1 mRNA | increases expression | 16517059 |
| C053400 | cafestol | [cafestol co-treated with kahweol palmitate] results in increased expression of NQO1 protein | affects cotreatment|increases expression | 11309284 |
| C053400 | cafestol | [cafestol co-treated with kahweol] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 18028974 |
| C053400 | cafestol | [cafestol co-treated with kahweol] results in increased expression of NQO1 protein | affects cotreatment|increases expression | 18028974 |
| C053400 | cafestol | NFE2L2 protein promotes the reaction [[cafestol co-treated with kahweol] results in increased expression of NQO1 mRNA] | affects cotreatment|increases expression|increases reaction | 18028974 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of NQO1 mRNA | affects expression | 17484886 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NQO1 mRNA | increases expression | 15496496 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of NQO1 mRNA | decreases expression | 16239168 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NQO1 mRNA | increases expression | 15976192 |
| C034221 | catechol | catechol results in increased expression of NQO1 mRNA | increases expression | 8652659 |
| D002509 | Cephaloridine | Cephaloridine results in increased expression of NQO1 mRNA | increases expression | 18172885 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of NQO1 mRNA | increases expression | 18178546 11323195 |
| D002726 | Chlorogenic Acid | Chlorogenic Acid results in increased activity of NQO1 protein | increases activity | 15944151 |
| C007020 | chlorophyllin | chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 19152381 |
| C007020 | chlorophyllin | chlorophyllin results in increased expression of NQO1 mRNA | increases expression | 19152381 |
| D002857 | Chromium | [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 17682057 |
| D002857 | Chromium | Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 17682057 |
| D002857 | Chromium | Butyrates inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 17682057 |
| D002857 | Chromium | Chromium inhibits the reaction [Benzo(a)pyrene results in increased activity of NQO1 protein] | decreases reaction|increases activity | 15337587 |
| D002857 | Chromium | Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15337587 17682057 |
| D002857 | Chromium | Chromium inhibits the reaction [beta-Naphthoflavone results in increased activity of NQO1 protein] | decreases reaction|increases activity | 15337587 |
| D002857 | Chromium | Chromium inhibits the reaction [beta-Naphthoflavone results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15337587 |
| D002857 | Chromium | Chromium inhibits the reaction [Methylcholanthrene results in increased activity of NQO1 protein] | decreases reaction|increases activity | 15337587 |
| D002857 | Chromium | Chromium inhibits the reaction [Methylcholanthrene results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15337587 |
| D002857 | Chromium | Chromium inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | decreases reaction|increases activity | 18474416 15337587 |
| D002857 | Chromium | Chromium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 18474416 15337587 |
| D002857 | Chromium | Chromium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D002857 | Chromium | Chromium results in increased degradation of NQO1 mRNA | increases degradation | 18474416 |
| D002857 | Chromium | Chromium results in increased expression of NQO1 mRNA | increases expression | 18474416 |
| D002857 | Chromium | Cycloheximide promotes the reaction [Chromium results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 18474416 |
| D002857 | Chromium | Dactinomycin promotes the reaction [Chromium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression|increases reaction | 18474416 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in decreased expression of NQO1 mRNA | decreases expression | 16517059 |
| C031180 | chrysene | chrysene results in increased activity of NQO1 protein | increases activity | 16906435 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in increased expression of NQO1 mRNA | increases expression | 19033392 |
| C019304 | ciprofibrate | ciprofibrate results in increased expression of NQO1 mRNA | increases expression | 7676460 |
| D002994 | Clofibrate | Clofibrate results in increased expression of NQO1 mRNA | increases expression | 17627975 |
| D003033 | Coal Tar | Coal Tar results in increased expression of NQO1 mRNA | increases expression | 16882163 |
| D003069 | Coffee | Coffee results in increased expression of NQO1 mRNA | increases expression | 18028974 |
| D003069 | Coffee | Coffee results in increased expression of NQO1 protein | increases expression | 18028974 |
| D003069 | Coffee | NFE2L2 protein promotes the reaction [Coffee results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 18028974 |
| D003300 | Copper | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide promotes the reaction [Copper results in decreased expression of NQO1 mRNA]] | decreases expression|decreases reaction|increases reaction | 16243960 |
| D003300 | Copper | Copper inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | decreases reaction|increases activity | 16243960 |
| D003300 | Copper | Copper inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 |
| D003300 | Copper | Copper results in decreased expression of NQO1 mRNA | decreases expression | 16243960 |
| D003300 | Copper | Copper results in increased activity of NQO1 protein | increases activity | 16243960 |
| D003300 | Copper | Cycloheximide promotes the reaction [Copper results in decreased expression of NQO1 mRNA] | decreases expression|increases reaction | 16243960 |
| C030123 | coumarin | coumarin results in increased expression of NQO1 protein | increases expression | 11309284 |
| C030123 | coumarin | coumarin results in increased expression of NQO1 mRNA | increases expression | 18480146 |
| C028419 | cuprous chloride | cuprous chloride results in increased activity of NQO1 protein | increases activity | 9029048 |
| C028419 | cuprous chloride | cuprous chloride results in increased expression of NQO1 mRNA | increases expression | 9029048 |
| D003474 | Curcumin | Curcumin results in increased expression of NQO1 mRNA | increases expression | 17198877 19188863 |
| D003474 | Curcumin | Curcumin results in increased expression of NQO1 protein | increases expression | 19188863 |
| D003474 | Curcumin | Curcumin results in increased activity of NQO1 protein | increases activity | 18321868 |
| D003474 | Curcumin | Curcumin results in increased expression of NQO1 mRNA | increases expression | 18321868 17535857 |
| D003474 | Curcumin | Curcumin results in increased expression of NQO1 protein | increases expression | 18321868 |
| D003474 | Curcumin | Curcumin results in increased expression of NQO1 mRNA | increases expression | 18299980 |
| D003474 | Curcumin | Curcumin results in decreased expression of NQO1 | decreases expression | 18462866 |
| C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of NQO1 mRNA | increases expression | 17654400 |
| D003513 | Cycloheximide | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Lead results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 16243960 |
| D003513 | Cycloheximide | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Mercury results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 16243960 |
| D003513 | Cycloheximide | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 16243960 |
| D003513 | Cycloheximide | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide promotes the reaction [Copper results in decreased expression of NQO1 mRNA]] | decreases expression|decreases reaction|increases reaction | 16243960 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 14510636 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [arsenite results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 18474416 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Cadmium results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 18474416 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Lead results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Mercury results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 18474416 16243960 14510636 |
| D003513 | Cycloheximide | Cycloheximide promotes the reaction [Chromium results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 18474416 |
| D003513 | Cycloheximide | Cycloheximide promotes the reaction [Copper results in decreased expression of NQO1 mRNA] | decreases expression|increases reaction | 16243960 |
| D003513 | Cycloheximide | Cycloheximide results in decreased expression of NQO1 mRNA | decreases expression | 18474416 16243960 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in decreased expression of NQO1 mRNA | decreases expression | 11906922 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Lead results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Mercury results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 18474416 16243960 |
| D003609 | Dactinomycin | Dactinomycin promotes the reaction [Chromium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression|increases reaction | 18474416 |
| C004742 | daidzein | daidzein results in decreased expression of NQO1 mRNA | decreases expression | 18497090 |
| C014347 | decitabine | decitabine results in decreased methylation of NQO1 promoter | decreases methylation | 15763338 |
| C014347 | decitabine | decitabine results in increased expression of NQO1 mRNA | increases expression | 19194470 |
| D003703 | Demecolcine | Demecolcine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 11602686 |
| C050229 | demethoxycurcumin | demethoxycurcumin results in increased expression of NQO1 mRNA | increases expression | 19188863 |
| C050229 | demethoxycurcumin | demethoxycurcumin results in increased expression of NQO1 protein | increases expression | 19188863 |
| C050229 | demethoxycurcumin | demethoxycurcumin results in increased expression of NQO1 mRNA | increases expression | 17535857 |
| D003907 | Dexamethasone | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 17690134 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression|increases reaction | 17690134 |
| D016190 | Carboplatin | Carboplatin results in increased expression of NQO1 mRNA | increases expression | 18172885 |
| C029108 | diaziquone | NQO1 protein results in increased metabolism of diaziquone | increases metabolic processing | 9343371 |
| C029108 | diaziquone | [NQO1 protein results in increased metabolism of diaziquone] which results in increased abundance of Hydrogen Peroxide | increases abundance|increases metabolic processing | 9343371 |
| C029108 | diaziquone | [NQO1 protein results in increased metabolism of diaziquone] which results in increased expression of CDKN1A mRNA | increases expression|increases metabolic processing | 9343371 |
| D002945 | Cisplatin | Cisplatin results in increased expression of NQO1 mRNA | increases expression | 18172885 |
| D004008 | Diclofenac | Diclofenac results in increased activity of NQO1 protein | increases activity | 8572925 |
| D004008 | Diclofenac | Diclofenac results in increased expression of NQO1 mRNA | increases expression | 18172885 |
| D001728 | Dicumarol | Dicumarol inhibits the reaction [TP53 protein binds to NQO1 protein] | affects binding|decreases reaction | 14634213 |
| D001728 | Dicumarol | Dicumarol results in decreased activity of NQO1 protein | decreases activity | 17669387 8572925 15805261 11154737 |
| D001728 | Dicumarol | NQO1 protein affects the susceptibility to Dicumarol | affects response to substance | 10531305 |
| D001728 | Dicumarol | NQO1 protein inhibits the reaction [Dicumarol results in decreased activity of MAPK10 protein] | decreases activity|decreases reaction | 10531305 |
| D001728 | Dicumarol | Dicumarol results in decreased activity of NQO1 protein | decreases activity | 10092053 |
| D001728 | Dicumarol | Dicumarol inhibits the reaction [Benzo(a)pyrene results in increased activity of NQO1 protein] | decreases reaction|increases activity | 19497421 |
| D001728 | Dicumarol | Dicumarol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | decreases reaction|increases activity | 19497421 |
| D001728 | Dicumarol | Dicumarol results in decreased activity of NQO1 protein | decreases activity | 19497421 |
| D001728 | Dicumarol | Dicumarol results in decreased activity of NQO1 protein | decreases activity | 16061648 14634213 9310146 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of NQO1 mRNA | increases expression | 18042831 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of NQO1 mRNA | increases expression | 17627975 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased activity of NQO1 protein | decreases activity | 9212780 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 20101389 |
| D004052 | Diethylnitrosamine | [Piperonyl Butoxide co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 19690152 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 18164116 21295105 20045035 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 20033131 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 20033131 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 20033131 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of NQO1 mRNA | increases expression | 19638242 |
| D004052 | Diethylnitrosamine | [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 18754104 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of NQO1 mRNA | increases expression | 15890375 |
| C015144 | dihydrolipoic acid | dihydrolipoic acid results in increased activity of NQO1 protein | increases activity | 18838692 |
| D015102 | 3,4-Dihydroxyphenylacetic Acid | 3,4-Dihydroxyphenylacetic Acid results in increased expression of NQO1 mRNA | increases expression | 19743802 |
| D004112 | Dimercaprol | [Dimercaprol co-treated with Mercuric Chloride] results in increased activity of NQO1 protein | affects cotreatment|increases activity | 18838692 |
| D004112 | Dimercaprol | Dimercaprol results in increased activity of NQO1 protein | increases activity | 18838692 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | NQO1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene | affects response to substance | 21042282 |
| C056020 | dimethyl fumarate | dimethyl fumarate results in increased activity of NQO1 protein | increases activity | 16045903 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of NQO1 mRNA | increases expression | 15890375 14600272 15976192 |
| C547156 | dimethylthioarsinic acid | dimethylthioarsinic acid results in increased expression of NQO1 mRNA | increases expression | 19945496 |
| D004137 | Dinitrochlorobenzene | Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 19033392 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of NQO1 mRNA | increases expression | 19033392 16314067 |
| D004178 | Diquat | Diquat results in increased activity of NQO1 protein | increases activity | 21172416 |
| D004178 | Diquat | Diquat results in increased expression of NQO1 mRNA | increases expression | 21172416 |
| D004178 | Diquat | Diquat results in increased expression of NQO1 protein | increases expression | 21172416 |
| D004178 | Diquat | Diquat results in increased expression of NQO1 mRNA | increases expression | 20826540 |
| D004178 | Diquat | PROP1 protein affects the reaction [Diquat results in increased expression of NQO1 mRNA] | affects reaction|increases expression | 20826540 |
| D004221 | Disulfiram | Disulfiram results in increased activity of NQO1 protein | increases activity | 16045903 |
| C034257 | duroquinone | NQO1 protein results in increased reduction of duroquinone | increases reduction | 16243901 |
| D004391 | Dust | Dust results in increased expression of NQO1 mRNA | increases expression | 17805423 |
| C042986 | ebselen | ebselen results in decreased activity of NQO1 protein | decreases activity | 7590103 |
| C073539 | erucin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [erucin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15896333 |
| C073539 | erucin | erucin results in increased expression of NQO1 mRNA | increases expression | 15896333 |
| C073539 | erucin | PD 98059 inhibits the reaction [erucin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15896333 |
| D004958 | Estradiol | Estradiol inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased activity of NQO1 protein] | decreases reaction|increases activity | 16219370 |
| D004958 | Estradiol | Estradiol results in decreased expression of NQO1 mRNA | decreases expression | 18497090 |
| D004958 | Estradiol | Estradiol results in increased activity of NQO1 protein | increases activity | 12088631 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of NQO1 mRNA | affects expression | 17555576 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of NQO1 mRNA | increases expression | 17942748 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of NQO1 mRNA | increases expression | 16926038 |
| D005015 | Ethoxyquin | Ethoxyquin results in increased expression of NQO1 mRNA | increases expression | 19144771 15919853 17627975 |
| D005015 | Ethoxyquin | Ethoxyquin results in increased expression of NQO1 protein | increases expression | 11309284 |
| D005015 | Ethoxyquin | Ethoxyquin results in increased activity of NQO1 protein | increases activity | 16045903 16906435 |
| D005015 | Ethoxyquin | Methylcholanthrene promotes the reaction [Ethoxyquin results in increased activity of NQO1 protein] | increases activity|increases reaction | 16906435 |
| D005047 | Etoposide | NQO1 protein affects the susceptibility to Etoposide | affects response to substance | 16217747 |
| D028441 | F2-Isoprostanes | NQO1 protein affects the reaction [Ozone results in increased metabolism of F2-Isoprostanes] | affects reaction|increases metabolic processing | 19059883 |
| D028441 | F2-Isoprostanes | NQO1 protein affects the metabolism of F2-Isoprostanes | affects metabolic processing | 19059883 |
| D005204 | Farnesol | Farnesol results in increased activity of NQO1 protein | increases activity | 15840382 |
| C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate results in increased expression of NQO1 mRNA | increases expression | 18617210 |
| C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate results in increased expression of NQO1 protein | increases expression | 18617210 |
| D005419 | Flavonoids | Flavonoids results in increased expression of NQO1 mRNA | increases expression | 18035473 |
| D005480 | Flurbiprofen | Flurbiprofen results in increased activity of NQO1 protein | increases activity | 8572925 |
| D005485 | Flutamide | Flutamide results in increased expression of NQO1 mRNA | increases expression | 21203749 |
| C039281 | furan | furan results in increased expression of NQO1 mRNA | increases expression | 15120968 |
| C001277 | geldanamycin | NQO1 protein results in increased reduction of geldanamycin | increases reduction | 16825487 |
| D019833 | Genistein | Genistein results in decreased expression of NQO1 mRNA | decreases expression | 18497090 |
| D019833 | Genistein | Genistein results in increased expression of NQO1 mRNA | increases expression | 18847459 |
| C048308 | glucobrassicin | glucobrassicin analog inhibits the reaction [glucoraphanin results in increased activity of NQO1 protein] | decreases reaction|increases activity | 20868228 |
| C048308 | glucobrassicin | glucobrassicin analog results in decreased activity of NQO1 protein | decreases activity | 20868228 |
| C119494 | glucoraphanin | glucobrassicin analog inhibits the reaction [glucoraphanin results in increased activity of NQO1 protein] | decreases reaction|increases activity | 20868228 |
| C119494 | glucoraphanin | glucoraphanin analog results in increased activity of NQO1 protein | increases activity | 20868228 |
| D005961 | Glucosinolates | Glucosinolates results in increased activity of NQO1 protein | increases activity | 15570060 |
| D005978 | Glutathione | Glutathione deficiency results in increased expression of NQO1 mRNA | increases expression | 15345336 |
| C071834 | glycidamide | glycidamide results in increased expression of NQO1 mRNA | increases expression | 17822822 |
| D017313 | Fenretinide | Fenretinide affects the expression of NQO1 mRNA | affects expression | 16570282 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of NQO1 mRNA | increases expression | 11008122 12414654 |
| D006861 | Hydrogen Peroxide | [NQO1 protein results in increased metabolism of diaziquone] which results in increased abundance of Hydrogen Peroxide | increases abundance|increases metabolic processing | 9343371 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of NQO1 mRNA | increases expression | 19497421 11008122 |
| D047348 | Hydrolyzable Tannins | Hydrolyzable Tannins results in decreased activity of NQO1 protein | decreases activity | 12749824 |
| C031927 | hydroquinone | hydroquinone results in increased expression of NQO1 mRNA | increases expression | 8652659 |
| D007052 | Ibuprofen | Ibuprofen affects the expression of NQO1 mRNA | affects expression | 17070997 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of NQO1 protein | increases expression | 11309284 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased activity of NQO1 protein | increases activity | 11446830 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of NQO1 | increases expression | 9806166 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of NQO1 mRNA | increases expression | 21203749 |
| C051890 | irinotecan | irinotecan analog results in decreased expression of NQO1 mRNA | decreases expression | 18927307 |
| D007501 | Iron | NQO1 protein results in increased reduction of Iron | increases reduction | 17178108 |
| D007529 | Isoflavones | Isoflavones results in increased expression of NQO1 mRNA | increases expression | 17374662 16365062 |
| C016527 | isoquercitrin | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 20033131 |
| D017879 | Isothiocyanates | Isothiocyanates results in increased expression of NQO1 protein | increases expression | 15570060 |
| D017879 | Isothiocyanates | Isothiocyanates results in increased expression of NQO1 protein | increases expression | 15570060 |
| C053401 | kahweol | [cafestol co-treated with kahweol] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 18028974 |
| C053401 | kahweol | [cafestol co-treated with kahweol] results in increased expression of NQO1 protein | affects cotreatment|increases expression | 18028974 |
| C053401 | kahweol | NFE2L2 protein promotes the reaction [[cafestol co-treated with kahweol] results in increased expression of NQO1 mRNA] | affects cotreatment|increases expression|increases reaction | 18028974 |
| C033997 | kahweol palmitate | [cafestol co-treated with kahweol palmitate] results in increased expression of NQO1 protein | affects cotreatment|increases expression | 11309284 |
| D007657 | Ketone Bodies | Ketone Bodies results in decreased expression of NQO1 mRNA | decreases expression | 16807920 |
| D007854 | Lead | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Lead results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 16243960 |
| D007854 | Lead | Cycloheximide inhibits the reaction [Lead results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 |
| D007854 | Lead | Dactinomycin inhibits the reaction [Lead results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 |
| D007854 | Lead | Lead promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | increases activity|increases reaction | 16243960 |
| D007854 | Lead | Lead promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 16243960 |
| D007854 | Lead | Lead results in increased activity of NQO1 protein | increases activity | 16243960 |
| D007854 | Lead | Lead results in increased expression of NQO1 mRNA | increases expression | 16243960 |
| D007854 | Lead | NFE2L2 protein affects the reaction [Lead results in increased expression of NQO1 mRNA] | affects reaction|increases expression | 16243960 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides inhibits the reaction [beta-Naphthoflavone results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15627257 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of NQO1 | decreases expression | 15627257 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of NQO1 mRNA | decreases expression | 15627257 |
| C115121 | LY 353381 | LY 353381 metabolite results in increased activity of NQO1 protein | increases activity | 17876041 |
| C115121 | LY 353381 | LY 353381 metabolite results in increased activity of NQO1 protein | increases activity | 17876041 |
| C115121 | LY 353381 | LY 353381 metabolite results in increased expression of and results in increased activity of NQO1 protein | increases activity|increases expression | 17876041 |
| C115121 | LY 353381 | LY 353381 results in increased expression of and results in increased activity of NQO1 protein | increases activity|increases expression | 17876041 |
| D008550 | Melatonin | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 20033131 |
| D008627 | Mercuric Chloride | [Dimercaprol co-treated with Mercuric Chloride] results in increased activity of NQO1 protein | affects cotreatment|increases activity | 18838692 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased activity of NQO1 protein | increases activity | 18838692 |
| D008628 | Mercury | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Mercury results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 16243960 |
| D008628 | Mercury | Cycloheximide inhibits the reaction [Mercury results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 |
| D008628 | Mercury | Dactinomycin inhibits the reaction [Mercury results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 |
| D008628 | Mercury | Mercury promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | increases activity|increases reaction | 16243960 |
| D008628 | Mercury | Mercury promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 16243960 |
| D008628 | Mercury | Mercury results in increased activity of NQO1 protein | increases activity | 16243960 |
| D008628 | Mercury | Mercury results in increased expression of NQO1 mRNA | increases expression | 16243960 |
| D008628 | Mercury | NFE2L2 protein affects the reaction [Mercury results in increased expression of NQO1 mRNA] | affects reaction|increases expression | 16243960 |
| D008701 | Methapyrilene | Methapyrilene results in increased expression of NQO1 mRNA | increases expression | 15890375 |
| D008727 | Methotrexate | Methotrexate results in decreased expression of NQO1 mRNA | decreases expression | 15120968 |
| C455529 | methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate | methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate results in increased activity of NQO1 protein | increases activity | 18838692 |
| D008748 | Methylcholanthrene | Arsenic promotes the reaction [Methylcholanthrene results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D008748 | Methylcholanthrene | Cadmium promotes the reaction [Methylcholanthrene results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D008748 | Methylcholanthrene | Chromium inhibits the reaction [Methylcholanthrene results in increased activity of NQO1 protein] | decreases reaction|increases activity | 15337587 |
| D008748 | Methylcholanthrene | Chromium inhibits the reaction [Methylcholanthrene results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15337587 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of NQO1 protein | increases activity | 15337587 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of NQO1 mRNA | increases expression | 15337587 20713471 |
| D008748 | Methylcholanthrene | Methylcholanthrene promotes the reaction [Buthionine Sulfoximine results in increased activity of NQO1 protein] | increases activity|increases reaction | 16906435 |
| D008748 | Methylcholanthrene | Methylcholanthrene promotes the reaction [Ethoxyquin results in increased activity of NQO1 protein] | increases activity|increases reaction | 16906435 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of NQO1 protein | increases activity | 16906435 15302093 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of NQO1 mRNA | increases expression | 17069994 11323195 |
| D008748 | Methylcholanthrene | [protocatechuic acid co-treated with Methylcholanthrene] results in increased activity of NQO1 protein | affects cotreatment|increases activity | 15302093 |
| D020366 | Methylmethacrylate | Methylmethacrylate results in increased expression of NQO1 mRNA | increases expression | 16916219 |
| C008493 | methylselenic acid | methylselenic acid results in increased activity of NQO1 protein | increases activity | 14617803 |
| D015735 | Mifepristone | Mifepristone results in decreased expression of NQO1 mRNA | decreases expression | 17584828 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression|increases reaction | 17690134 |
| D016685 | Mitomycin | NQO1 mRNA results in increased susceptibility to Mitomycin | increases response to substance | 15239142 |
| D016685 | Mitomycin | NQO1 protein affects the susceptibility to Mitomycin | affects response to substance | 16217747 |
| D016685 | Mitomycin | NQO1 protein results in increased metabolism of and results in increased susceptibility to Mitomycin | increases metabolic processing|increases response to substance | 9865924 |
| C082290 | molybdenum trioxide | molybdenum trioxide results in increased activity of NQO1 protein | increases activity | 9029048 |
| C082290 | molybdenum trioxide | molybdenum trioxide results in increased expression of NQO1 mRNA | increases expression | 9029048 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of NQO1 mRNA | increases expression | 19945496 |
| C028473 | N-acetyl-4-benzoquinoneimine | KEAP1 protein inhibits the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] | decreases reaction|increases metabolic processing | 19246624 |
| C028473 | N-acetyl-4-benzoquinoneimine | N-acetyl-4-benzoquinoneimine results in increased expression of NQO1 mRNA | increases expression | 18785192 |
| C028473 | N-acetyl-4-benzoquinoneimine | NFE2L2 protein affects the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of NQO1 mRNA] | affects reaction|increases expression | 18785192 |
| C028473 | N-acetyl-4-benzoquinoneimine | NFE2L2 protein promotes the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] | increases metabolic processing|increases reaction | 19246624 |
| C028473 | N-acetyl-4-benzoquinoneimine | NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine | increases metabolic processing | 19246624 |
| C005503 | naphthazarin | naphthazarin results in increased activity of NQO1 protein | increases activity | 15871734 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of NQO1 mRNA | increases expression | 15913567 |
| C529068 | naringenin-7-O-glucoside | naringenin-7-O-glucoside results in increased expression of NQO1 protein | increases expression | 18652870 |
| C498045 | NCX 4040 | NCX 4040 results in increased activity of NQO1 protein | increases activity | 17975886 |
| D009532 | Nickel | Nickel results in increased expression of NQO1 mRNA | increases expression | 19033392 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of NQO1 mRNA | increases expression | 16314067 19033392 |
| C102148 | nitroaspirin | nitroaspirin results in increased activity of NQO1 protein | increases activity | 17975886 |
| D009582 | Nitrofurantoin | NQO1 protein affects the reduction of Nitrofurantoin | affects reduction | 9310146 |
| D009582 | Nitrofurantoin | NQO1 protein results in decreased susceptibility to Nitrofurantoin | decreases response to substance | 9310146 |
| D009582 | Nitrofurantoin | NQO1 protein affects the reduction of Nitrofurantoin | affects reduction | 9310146 |
| D009582 | Nitrofurantoin | NQO1 protein results in increased susceptibility to Nitrofurantoin | increases response to substance | 9310146 |
| D009582 | Nitrofurantoin | Nitrofurantoin results in increased activity of NQO1 protein | increases activity | 12088631 |
| D015112 | 4-Nitroquinoline-1-oxide | NQO1 protein results in increased reduction of 4-Nitroquinoline-1-oxide | increases reduction | 9310146 |
| D015112 | 4-Nitroquinoline-1-oxide | NQO1 protein results in increased susceptibility to 4-Nitroquinoline-1-oxide | increases response to substance | 9310146 |
| D015112 | 4-Nitroquinoline-1-oxide | NQO1 protein results in decreased susceptibility to 4-Nitroquinoline-1-oxide | decreases response to substance | 9310146 |
| D015112 | 4-Nitroquinoline-1-oxide | NQO1 protein results in increased reduction of 4-Nitroquinoline-1-oxide | increases reduction | 9310146 |
| C107010 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 12540782 |
| C014138 | octachlorostyrene | octachlorostyrene results in increased expression of NQO1 mRNA | increases expression | 18036774 |
| D009828 | Oleanolic Acid | NFE2L2 protein affects the reaction [Oleanolic Acid results in increased activity of NQO1 protein] | affects reaction|increases activity | 19283895 |
| D009828 | Oleanolic Acid | NFE2L2 protein affects the reaction [Oleanolic Acid results in increased expression of NQO1 protein] | affects reaction|increases expression | 19283895 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in increased activity of NQO1 protein | increases activity | 19283895 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in increased expression of NQO1 mRNA | increases expression | 18706400 19283895 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in increased expression of NQO1 protein | increases expression | 19283895 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in increased expression of NQO1 mRNA | increases expression | 18706400 |
| C026209 | oltipraz | oltipraz results in increased activity of NQO1 protein | increases activity | 12407167 |
| C026209 | oltipraz | oltipraz results in increased expression of NQO1 mRNA | increases expression | 19144771 15919853 17627975 |
| C026209 | oltipraz | oltipraz results in increased expression of NQO1 protein | increases expression | 11309284 |
| C011030 | oxfendazole | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 20033131 |
| C011030 | oxfendazole | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 20033131 |
| C011030 | oxfendazole | [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 20033131 |
| C011030 | oxfendazole | [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 18754104 |
| C029341 | oxophenylarsine | oxophenylarsine results in increased expression of NQO1 mRNA | increases expression | 19786557 |
| D010126 | Ozone | GSTM1 gene polymorphism promotes the reaction [NQO1 gene SNP results in increased susceptibility to Ozone] | increases reaction|increases response to substance | 17652311 |
| D010126 | Ozone | NQO1 protein affects the reaction [Ozone results in increased metabolism of F2-Isoprostanes] | affects reaction|increases metabolic processing | 19059883 |
| D010126 | Ozone | NQO1 protein promotes the reaction [Ozone results in increased expression of IL8 mRNA] | increases expression|increases reaction | 19059883 |
| D010126 | Ozone | NQO1 protein promotes the reaction [Ozone results in increased expression of CXCL1 protein] | increases expression|increases reaction | 19059883 |
| D010126 | Ozone | NQO1 protein results in increased susceptibility to Ozone | increases response to substance | 19059883 |
| C041786 | palm oil | palm oil results in increased expression of NQO1 mRNA | increases expression | 18042831 |
| D010269 | Paraquat | Paraquat results in increased expression of NQO1 mRNA | increases expression | 17409708 |
| D010269 | Paraquat | Paraquat results in increased activity of NQO1 protein | increases activity | 15871734 |
| D010269 | Paraquat | Paraquat affects the expression of NQO1 mRNA | affects expression | 16854511 |
| D010269 | Paraquat | Paraquat results in increased activity of NQO1 protein | increases activity | 10699569 |
| D010269 | Paraquat | Paraquat results in increased expression of NQO1 mRNA | increases expression | 17935786 16328009 |
| D010269 | Paraquat | Paraquat results in increased expression of NQO1 protein | increases expression | 16328009 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [AHR protein results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 12758056 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [erucin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15896333 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [SQSTM1 protein results in increased expression of NQO1 protein] | decreases reaction|increases expression | 17360324 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid affects the expression of NQO1 mRNA | affects expression | 17383973 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid affects the expression of NQO1 mRNA | affects expression | 17383973 |
| C031181 | phenanthrene | phenanthrene results in increased activity of NQO1 protein | increases activity | 16906435 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased expression of NQO1 mRNA | increases expression | 15672752 |
| C015429 | phenidone | phenidone results in decreased activity of NQO1 protein | decreases activity | 11154737 |
| D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NQO1 mRNA] | affects reaction|increases expression | 19482888 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of NQO1 mRNA | affects expression | 19136022 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of NQO1 mRNA | increases expression | 19270015 19482888 |
| D019800 | Phenol | Phenol results in increased activity of NQO1 protein | increases activity | 9029048 |
| D019800 | Phenol | Phenol results in increased expression of NQO1 mRNA | increases expression | 9029048 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Spermidine results in increased activity of NQO1 protein] | decreases reaction|increases activity | 12763045 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Spermidine results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 12763045 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Spermine results in increased activity of NQO1 protein] | decreases reaction|increases activity | 12763045 |
| D010882 | Piperonyl Butoxide | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 20101389 |
| D010882 | Piperonyl Butoxide | [Piperonyl Butoxide co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 19690152 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of NQO1 mRNA | increases expression | 19690152 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of NQO1 mRNA | increases expression | 15890375 18544911 |
| D010882 | Piperonyl Butoxide | Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 18544911 |
| C006253 | pirinixic acid | pirinixic acid affects the expression of NQO1 mRNA | affects expression | 19136022 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of NQO1 mRNA | increases expression | 18301758 20059764 17950772 |
| C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 20059764 17950772 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of NQO1 mRNA | increases expression | 15890375 |
| D010936 | Plant Extracts | Plant Extracts results in increased activity of NQO1 protein | increases activity | 15560888 |
| D010936 | Plant Extracts | Plant Extracts results in increased activity of NQO1 protein | increases activity | 15570060 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of NQO1 protein | increases expression | 15570060 |
| D010936 | Plant Extracts | Plant Extracts results in increased activity of NQO1 protein | increases activity | 19650632 |
| D010936 | Plant Extracts | Selenium promotes the reaction [Plant Extracts results in increased activity of NQO1 protein] | increases activity|increases reaction | 19650632 |
| C095911 | polycyclic aromatic hydrocarbons-DNA adduct | NQO1 protein polymorphism results in increased abundance of polycyclic aromatic hydrocarbons-DNA adduct | increases abundance | 11967624 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | NQO1 gene polymorphism affects the susceptibility to Polycyclic Hydrocarbons, Aromatic | affects response to substance | 15061915 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in increased expression of NQO1 mRNA | increases expression | 17627975 |
| C045950 | propiconazole | propiconazole affects the expression of NQO1 mRNA | affects expression | 17383973 |
| C009091 | protocatechuic acid | [protocatechuic acid co-treated with Methylcholanthrene] results in increased activity of NQO1 protein | affects cotreatment|increases activity | 15302093 |
| C009091 | protocatechuic acid | protocatechuic acid results in increased activity of NQO1 protein | increases activity | 15302093 |
| C031280 | pyrazole | pyrazole results in increased expression of NQO1 mRNA | increases expression | 17945193 |
| C030984 | pyrene | pyrene results in increased activity of NQO1 protein | increases activity | 16906435 |
| D011794 | Quercetin | Quercetin results in increased expression of and results in increased activity of NQO1 protein | increases activity|increases expression | 11275421 |
| D011794 | Quercetin | Quercetin results in increased expression of NQO1 mRNA | increases expression | 11275421 |
| D011794 | Quercetin | Quercetin affects the expression of NQO1 mRNA | affects expression | 18178720 |
| D011809 | Quinones | NQO1 protein affects the metabolism of Quinones | affects metabolic processing | 15871734 |
| C059514 | resveratrol | resveratrol affects the localization of NQO1 protein | affects localization | 19138946 |
| C059514 | resveratrol | resveratrol results in increased expression of and affects the localization of NQO1 protein | affects localization|increases expression | 16759640 |
| C059514 | resveratrol | resveratrol results in increased expression of and results in increased activity of NQO1 protein | increases activity|increases expression | 16948474 |
| C059514 | resveratrol | resveratrol results in increased expression of NQO1 mRNA | increases expression | 12632063 16948474 |
| C059514 | resveratrol | resveratrol results in increased expression of NQO1 protein | increases expression | 19138946 |
| C059514 | resveratrol | resveratrol analog results in increased activity of NQO1 protein | increases activity | 17316918 |
| C059514 | resveratrol | resveratrol results in increased activity of NQO1 protein | increases activity | 17316918 |
| C059514 | resveratrol | resveratrol results in increased activity of NQO1 protein | increases activity | 16169743 |
| C059514 | resveratrol | resveratrol results in increased expression of NQO1 mRNA | increases expression | 16169743 |
| C064758 | Ro 31-8220 | Ro 31-8220 inhibits the reaction [DPP3 protein results in increased expression of NQO1 protein] | decreases reaction|increases expression | 17360324 |
| C064758 | Ro 31-8220 | Ro 31-8220 inhibits the reaction [SQSTM1 protein results in increased expression of NQO1 protein] | decreases reaction|increases expression | 17360324 |
| C116926 | rofecoxib | rofecoxib affects the expression of NQO1 mRNA | affects expression | 17070997 |
| C018381 | salvin | salvin results in increased expression of NQO1 mRNA | increases expression | 18329808 |
| C515055 | S-(dimethylarsino)-glutathione | S-(dimethylarsino)-glutathione results in increased expression of NQO1 mRNA | increases expression | 19417148 |
| C014811 | selenaproline | selenaproline results in increased expression of NQO1 mRNA | increases expression | 16451816 |
| D012643 | Selenium | Selenium affects the activity of NQO1 protein | affects activity | 18279678 |
| D012643 | Selenium | [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 11444866 |
| D012643 | Selenium | Selenium deficiency results in increased expression of NQO1 mRNA | increases expression | 11444866 |
| D012643 | Selenium | Selenium promotes the reaction [Plant Extracts results in increased activity of NQO1 protein] | increases activity|increases reaction | 19650632 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of NQO1 mRNA | increases expression | 12727804 |
| C009277 | sodium arsenate | sodium arsenate results in increased activity of NQO1 protein | increases activity | 18838692 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of NQO1 mRNA | increases expression | 17409708 12426128 20473585 12377979 20100676 |
| C017947 | sodium arsenite | Ascorbic Acid promotes the reaction [sodium arsenite results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 16517059 |
| C017947 | sodium arsenite | sodium arsenite promotes the reaction [[NFE2L2 protein binds to MAFG protein] which binds to NQO1 promoter] | affects binding|increases reaction | 16785233 |
| C017947 | sodium arsenite | sodium arsenite promotes the reaction [[NFE2L2 protein binds to MAFK protein] which binds to NQO1 promoter] | affects binding|increases reaction | 16785233 |
| C017947 | sodium arsenite | sodium arsenite results in increased activity of NQO1 protein | increases activity | 11979426 18838692 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of NQO1 mRNA | increases expression | 16517059 11979426 16785233 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of NQO1 mRNA | increases expression | 16451816 |
| D013095 | Spermidine | pimagedine inhibits the reaction [Spermidine results in increased activity of NQO1 protein] | decreases reaction|increases activity | 12763045 |
| D013095 | Spermidine | pimagedine inhibits the reaction [Spermidine results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 12763045 |
| D013095 | Spermidine | Spermidine results in increased activity of NQO1 protein | increases activity | 12763045 |
| D013095 | Spermidine | Spermidine results in increased expression of NQO1 mRNA | increases expression | 12763045 |
| D013096 | Spermine | pimagedine inhibits the reaction [Spermine results in increased activity of NQO1 protein] | decreases reaction|increases activity | 12763045 |
| D013096 | Spermine | Spermine results in increased activity of NQO1 protein | increases activity | 12763045 |
| D013308 | Streptonigrin | NQO1 protein results in increased metabolism of Streptonigrin | increases metabolic processing | 7620217 |
| D020058 | Styrene | NQO1 gene polymorphism affects the susceptibility to Styrene | affects response to substance | 14979085 |
| C033006 | sudan III | sudan III results in increased expression of NQO1 mRNA | increases expression | 20308224 |
| C016766 | sulforafan | sulforafan results in increased activity of NQO1 protein | increases activity | 20868228 |
| C016766 | sulforafan | sulforafan results in increased expression of NQO1 mRNA | increases expression | 19033392 15672752 15896333 |
| C016766 | sulforafan | sulforafan affects the localization of NQO1 protein | affects localization | 19367690 |
| C016766 | sulforafan | sulforafan results in increased activity of NQO1 protein | increases activity | 18838692 19367690 |
| C016766 | sulforafan | sulforafan results in increased expression of NQO1 mRNA | increases expression | 19367690 |
| C016766 | sulforafan | sulforafan results in increased expression of NQO1 protein | increases expression | 19367690 11309284 |
| C016766 | sulforafan | Vanadium inhibits the reaction [sulforafan affects the localization of NQO1 protein] | affects localization|decreases reaction | 19367690 |
| C016766 | sulforafan | Vanadium inhibits the reaction [sulforafan results in increased activity of NQO1 protein] | decreases reaction|increases activity | 19367690 |
| C016766 | sulforafan | Vanadium inhibits the reaction [sulforafan results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 19367690 |
| C016766 | sulforafan | Vanadium inhibits the reaction [sulforafan results in increased expression of NQO1 protein] | decreases reaction|increases expression | 19367690 |
| C016766 | sulforafan | sulforafan results in increased activity of NQO1 protein | increases activity | 15906351 |
| C016766 | sulforafan | sulforafan results in increased expression of NQO1 mRNA | increases expression | 11264000 |
| D013467 | Sulindac | Sulindac results in increased activity of NQO1 protein | increases activity | 17985343 |
| D013467 | Sulindac | Sulindac results in increased expression of NQO1 mRNA | increases expression | 17985343 11093808 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased activity of NQO1 protein | increases activity | 17985343 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased expression of NQO1 mRNA | increases expression | 17985343 |
| C025463 | sulindac sulfone | sulindac sulfone results in increased activity of NQO1 protein | increases activity | 17985343 |
| C025463 | sulindac sulfone | sulindac sulfone results in increased expression of NQO1 mRNA | increases expression | 17985343 |
| C446685 | systhane | systhane affects the expression of NQO1 mRNA | affects expression | 17383973 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of NQO1 mRNA | affects expression | 17555576 |
| C003377 | taxifolin | taxifolin results in increased activity of NQO1 protein | increases activity | 17541156 |
| C003377 | taxifolin | taxifolin results in increased expression of NQO1 mRNA | increases expression | 17541156 |
| D013749 | Tetrachlorodibenzodioxin | [Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]] which results in decreased expression of NQO1 mRNA | decreases expression|decreases reaction|increases expression | 15044633 |
| D013749 | Tetrachlorodibenzodioxin | Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 15044633 |
| D013749 | Tetrachlorodibenzodioxin | Acetylcysteine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein] | decreases reaction|increases expression | 15044633 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A1 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15044633 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] which results in increased expression of NQO1 mRNA | increases activity|increases expression | 15044633 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of NQO1 protein | increases activity | 9029048 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA | increases expression | 15044633 19542225 20395535 9029048 18762178 20106945 11489354 |
| D013749 | Tetrachlorodibenzodioxin | AG-879 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 11163336 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 19474220 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein] | increases expression|increases reaction | 19474220 |
| D013749 | Tetrachlorodibenzodioxin | Arsenic promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D013749 | Tetrachlorodibenzodioxin | arsenite affects the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | affects reaction|increases activity | 18474416 |
| D013749 | Tetrachlorodibenzodioxin | arsenite promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 18474416 |
| D013749 | Tetrachlorodibenzodioxin | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression | 16243960 |
| D013749 | Tetrachlorodibenzodioxin | Cadmium promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | increases activity|increases reaction | 18474416 |
| D013749 | Tetrachlorodibenzodioxin | Cadmium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 18474416 |
| D013749 | Tetrachlorodibenzodioxin | Chromium inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | decreases reaction|increases activity | 18474416 15337587 |
| D013749 | Tetrachlorodibenzodioxin | Chromium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 18474416 15337587 |
| D013749 | Tetrachlorodibenzodioxin | Chromium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 15337587 |
| D013749 | Tetrachlorodibenzodioxin | Copper inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | decreases reaction|increases activity | 16243960 |
| D013749 | Tetrachlorodibenzodioxin | Copper inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 |
| D013749 | Tetrachlorodibenzodioxin | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 18474416 14510636 |
| D013749 | Tetrachlorodibenzodioxin | Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 16243960 18474416 |
| D013749 | Tetrachlorodibenzodioxin | Dactinomycin promotes the reaction [Chromium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression|increases reaction | 18474416 |
| D013749 | Tetrachlorodibenzodioxin | Demecolcine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 11602686 |
| D013749 | Tetrachlorodibenzodioxin | Lead promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | increases activity|increases reaction | 16243960 |
| D013749 | Tetrachlorodibenzodioxin | Lead promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 16243960 |
| D013749 | Tetrachlorodibenzodioxin | Mercury promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | increases activity|increases reaction | 16243960 |
| D013749 | Tetrachlorodibenzodioxin | Mercury promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 16243960 |
| D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | affects reaction|increases expression | 19474220 |
| D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein] | affects reaction|increases expression | 19474220 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of NQO1 mRNA | affects expression | 18343893 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the localization of NQO1 protein | affects localization | 19367690 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of NQO1 mRNA | affects binding|increases expression | 16214954 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of NQO1 protein | increases activity | 18474416 16243960 15337587 19367690 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA | increases expression | 14510636 15667827 18691609 16243960 16960034 18372398 15337587 15800033 20159946 17627975 17942748 18796159 19367690 18474416 11602686 16611356 15328365 11163336 19933214 15251184 18163543 19474220 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NQO1 protein | increases expression | 19474220 19367690 |
| D013749 | Tetrachlorodibenzodioxin | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NQO1 protein] | affects localization|decreases reaction | 19367690 |
| D013749 | Tetrachlorodibenzodioxin | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | decreases reaction|increases activity | 19367690 |
| D013749 | Tetrachlorodibenzodioxin | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 19367690 |
| D013749 | Tetrachlorodibenzodioxin | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein] | decreases reaction|increases expression | 19367690 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NQO1 | increases expression | 15993909 |
| D013749 | Tetrachlorodibenzodioxin | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 17690134 |
| D013749 | Tetrachlorodibenzodioxin | Dicumarol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | decreases reaction|increases activity | 19497421 |
| D013749 | Tetrachlorodibenzodioxin | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]] | decreases reaction|increases expression|increases reaction | 17690134 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of NQO1 protein | increases activity | 19497421 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA | increases expression | 18178546 16960034 18796159 17069994 19497421 17690134 16054898 |
| D013752 | Tetracycline | Tetracycline results in decreased expression of NQO1 mRNA | decreases expression | 19224547 |
| D013755 | Tetradecanoylphorbol Acetate | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NQO1 mRNA | affects cotreatment|affects expression | 16979875 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of NQO1 mRNA | increases expression | 16337175 15976192 |
| D008063 | Thioctic Acid | Thioctic Acid results in increased activity of NQO1 protein | increases activity | 17940886 |
| D008063 | Thioctic Acid | Thioctic Acid results in increased expression of NQO1 mRNA | increases expression | 19033392 17940886 |
| D014050 | Toluene | Toluene results in increased activity of NQO1 protein | increases activity | 9029048 |
| D014050 | Toluene | Toluene results in increased expression of NQO1 mRNA | increases expression | 9029048 |
| D014212 | Tretinoin | Tretinoin results in increased expression of NQO1 mRNA | increases expression | 17431108 |
| C032910 | triadimefon | triadimefon affects the expression of NQO1 mRNA | affects expression | 17383973 |
| D014227 | Triazines | Triazines results in decreased activity of NQO1 protein | decreases activity | 11154737 |
| C010360 | triethyllead | triethyllead results in increased activity of NQO1 protein | increases activity | 9020200 |
| D014303 | Trinitrotoluene | Trinitrotoluene affects the expression of NQO1 mRNA | affects expression | 21346803 |
| D014315 | Triterpenes | Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of NQO1 mRNA] | increases expression|increases reaction | 18544911 |
| D014315 | Triterpenes | Triterpenes results in increased expression of NQO1 mRNA | increases expression | 18544911 |
| D014639 | Vanadium | Vanadium inhibits the reaction [sulforafan affects the localization of NQO1 protein] | affects localization|decreases reaction | 19367690 |
| D014639 | Vanadium | Vanadium inhibits the reaction [sulforafan results in increased activity of NQO1 protein] | decreases reaction|increases activity | 19367690 |
| D014639 | Vanadium | Vanadium inhibits the reaction [sulforafan results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 19367690 |
| D014639 | Vanadium | Vanadium inhibits the reaction [sulforafan results in increased expression of NQO1 protein] | decreases reaction|increases expression | 19367690 |
| D014639 | Vanadium | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NQO1 protein] | affects localization|decreases reaction | 19367690 |
| D014639 | Vanadium | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein] | decreases reaction|increases activity | 19367690 |
| D014639 | Vanadium | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | decreases reaction|increases expression | 19367690 |
| D014639 | Vanadium | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein] | decreases reaction|increases expression | 19367690 |
| D014639 | Vanadium | Vanadium results in decreased expression of NQO1 mRNA | decreases expression | 19367690 |
| D014639 | Vanadium | Vanadium results in increased stability of NQO1 protein | increases stability | 19367690 |
| C066075 | vanadium pentoxide | vanadium pentoxide results in increased expression of NQO1 mRNA | increases expression | 17459161 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of NQO1 mRNA | increases expression | 19465080 |
| D014810 | Vitamin E | [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of NQO1 mRNA | affects cotreatment|increases expression | 11444866 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased expression of NQO1 mRNA | increases expression | 12414654 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased activity of NQO1 protein | increases activity | 15871734 |
| C403304 | zerumbone | zerumbone results in increased expression of NQO1 mRNA | increases expression | 15122579 |
| D015032 | Zinc | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NQO1 mRNA | affects cotreatment|affects expression | 16979875 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 8.55 | 14745880 | |
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 8.55 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | 2-amino-4,6-dinitrotoluene | 24.16 | 7525203 | |
| MESH:D000014 | Abnormalities, Drug-Induced | 4-amino-2,6-dinitrotoluene | 24.16 | 7525203 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Diethylhexyl Phthalate | 24.16 | 6734493 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Disulfiram | 24.16 | 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Methotrexate | 24.16 | 12039119 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 24.16 | 6195326 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 24.16 | 15322242 14514962 11752688 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Trinitrotoluene | 24.16 | 7525203 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 2.25 | 18287403 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 2.60 | 17505938 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Disulfiram | 4.25 | 9207937 | |
| MESH:D000169 | Acrodermatitis | Zinc | 4.07 | 17190629 16889938 17202136 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 17.83 | 15814532 17670903 12690470 | |
| MESH:D058186 | Acute Kidney Injury | Diclofenac | 17.83 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | Ibuprofen | 17.83 | 6375363 | |
| MESH:D058186 | Acute Kidney Injury | Mercuric Chloride | 17.83 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 17.83 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 17.83 | 7897758 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 15.50 | 20525806 21297076 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 15.50 | 11850527 18653653 | |
| MESH:D055371 | Acute Lung Injury | Nickel | 15.50 | 16166738 | |
| MESH:D055371 | Acute Lung Injury | nickel sulfate | 15.50 | 12718980 11954676 16100012 19131640 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 15.50 | 18653653 | |
| MESH:D000230 | Adenocarcinoma | 9,10-Dimethyl-1,2-benzanthracene | 24.55 | 12844480 10697514 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 24.55 | 11798837 19825857 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 24.55 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 24.55 | 17638652 11798837 | |
| MESH:D000230 | Adenocarcinoma | daidzein | 24.55 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 24.55 | 16033868 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 24.55 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 24.55 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fenretinide | 24.55 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 24.55 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ibuprofen | 24.55 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 24.55 | 11910360 | |
| MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 27.45 | 16176798 | |
| MESH:D000236 | Adenoma | 9,10-Dimethyl-1,2-benzanthracene | 27.45 | 11376689 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 27.45 | 6695378 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 27.45 | 19389873 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 27.45 | 6695378 10737359 | |
| MESH:D000236 | Adenoma | Dimethylnitrosamine | 27.45 | 19555203 | |
| MESH:D000236 | Adenoma | Melatonin | 27.45 | 17195641 | |
| MESH:D000236 | Adenoma | Methylcholanthrene | 27.45 | 10545420 6695378 | |
| MESH:D000236 | Adenoma | resveratrol | 27.45 | 15688382 | |
| MESH:D000236 | Adenoma | Sulindac | 27.45 | 10223192 | |
| MESH:D018248 | Adenoma, Liver Cell | 3,4,5,3',4'-pentachlorobiphenyl | 18.93 | 16628245 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 18.93 | 19052882 17162532 16434500 18056438 19061943 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 18.93 | 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 18.93 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 18.93 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Flurbiprofen | 13.33 | 10680582 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulforafan | 13.33 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 13.33 | 19003578 11535846 17611924 11874996 15623613 16460482 12394442 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulindac sulfone | 13.33 | 16150858 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.35 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 9.32 | 17306315 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 9.32 | 16712894 17306315 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 2.52 | 11874814 | |
| MESH:D000437 | Alcoholism | Disulfiram | 3.86 | 17079463 10841824 18968458 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.73 | 17887948 | |
| MESH:D000505 | Alopecia | Isoflavones | 5.76 | 17569567 | |
| MESH:D000505 | Alopecia | Tretinoin | 5.76 | 15955085 | |
| MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 4.31 | 16640825 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 20.03 | 17570602 14715435 15207723 | |
| MESH:D000544 | Alzheimer Disease | bis(4-hydroxycinnamoyl)methane | 20.03 | 19090986 | |
| MESH:D000544 | Alzheimer Disease | Copper | 20.03 | 16866297 16325427 16410023 17119284 16962711 16886094 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 20.03 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Ibuprofen | 20.03 | 18351690 | |
| MESH:D000544 | Alzheimer Disease | Iron | 20.03 | 16640825 16563566 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 20.03 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 20.03 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 20.03 | 16183991 16162502 | |
| MESH:D000544 | Alzheimer Disease | sulindac sulfide | 20.03 | 18759972 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 20.03 | 17119284 16325427 16580781 16410023 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 3.20 | 15469931 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Copper | 3.32 | 10694572 | |
| MESH:D000707 | Anaphylaxis | Ibuprofen | 3.94 | 9532969 | |
| MESH:D000740 | Anemia | Iron | 4.95 | 16434484 16566752 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 4.95 | 11748828 | |
| MESH:D000741 | Anemia, Aplastic | Benzene | 3.24 | 11369114 17661222 14761424 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.01 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Copper | 6.45 | 16614410 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Iron | 6.45 | 17162259 17147795 16569441 17163184 17375513 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.61 | 16916123 | |
| MESH:D000756 | Anemia, Sideroblastic | Iron | 3.58 | 16910769 | |
| MESH:D000799 | Angioedema | Acetaminophen | 2.50 | 10982225 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 2.77 | 19183758 | |
| MESH:D001145 | Arrhythmias, Cardiac | Iron | 3.19 | 16604332 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.31 | 12569548 16251483 18414634 16835338 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 13.87 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 13.87 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Dietary Fats | 13.87 | 15238619 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 13.87 | 11256880 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 15.84 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 15.84 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 15.84 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 15.84 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | rofecoxib | 15.84 | 16690336 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 15.84 | 16412693 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 5.68 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Methotrexate | 5.68 | 17286800 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 5.68 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 5.68 | 16292516 | |
| MESH:D001249 | Asthma | Ozone | 4.07 | 16373670 17854713 | |
| MESH:D001249 | Asthma | Tretinoin | 4.07 | 16456186 | |
| MESH:D001249 | Asthma | Zinc | 4.07 | 17085522 | |
| MESH:D001260 | Ataxia Telangiectasia | Iron | 8.70 | 15336622 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 8.70 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Acrolein | 16.16 | 16126721 16037261 17363696 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 16.16 | 12928151 19371607 | |
| MESH:D050197 | Atherosclerosis | Cadmium | 16.16 | 15687053 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 16.16 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Iron | 16.16 | 16632123 16640825 | |
| MESH:D050197 | Atherosclerosis | Methylcholanthrene | 16.16 | 11922910 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 16.16 | 16873680 17967414 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 2.07 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 2.07 | 19056591 16917939 19267885 18929414 | |
| MESH:D001321 | Autistic Disorder | Iron | 2.07 | 17352947 | |
| MESH:D001321 | Autistic Disorder | Melatonin | 2.07 | 16897403 16919138 | |
| MESH:D001321 | Autistic Disorder | Mercury | 2.07 | 17497416 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 15.28 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Mercury | 15.28 | 16634805 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 15.28 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | sulforafan | 15.28 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Iron | 3.87 | 16640825 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 3.11 | 16935849 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 20.25 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | Clofibrate | 20.25 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 20.25 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 20.25 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Thioacetamide | 20.25 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 20.25 | 16197459 16206674 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.45 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 1.75 | 15746008 | |
| MESH:D001855 | Bone Marrow Diseases | Benzene | 3.88 | 16183116 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 12.76 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 12.76 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 12.76 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | Phenol | 3.96 | 10556009 | |
| MESH:D001913 | Bowen's Disease | Phenol | 8.48 | 19293009 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 8.48 | 11207687 | |
| MESH:D001930 | Brain Injuries | Zinc | 3.39 | 17109824 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 13.60 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Ibuprofen | 13.60 | 15837124 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 13.60 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 13.60 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Acrylonitrile | 11.22 | 12562636 | |
| MESH:D001932 | Brain Neoplasms | Copper | 11.22 | 17079463 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 11.22 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Fenretinide | 11.22 | 16187019 | |
| MESH:D001943 | Breast Neoplasms | marker/mechanism | 18511948 | ||
| MESH:D001943 | Breast Neoplasms | 2,4-diaminotoluene | 40.02 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 40.02 | 20146248 | |
| MESH:D001943 | Breast Neoplasms | 5-(1-aziridinyl)-2,4-dinitrobenzamide | 40.02 | 11859878 15665820 | |
| MESH:D001943 | Breast Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 40.02 | 16153821 17127718 20435547 18840765 15565634 | |
| MESH:D001943 | Breast Neoplasms | allyl sulfide | 40.02 | 17125941 | |
| MESH:D001943 | Breast Neoplasms | Ascorbic Acid | 40.02 | 16443354 | |
| MESH:D001943 | Breast Neoplasms | Benzene | 40.02 | 17162533 11921183 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 40.02 | 17474063 20146248 | |
| MESH:D001943 | Breast Neoplasms | Cacodylic Acid | 40.02 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Chromium | 40.02 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 40.02 | 18382427 19526202 | |
| MESH:D001943 | Breast Neoplasms | Copper | 40.02 | 17079463 15986119 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 40.02 | 19250217 16243823 18593918 18462866 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 40.02 | 11325840 17020986 12006526 18323546 17388661 15093573 18234424 15136595 16978400 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 40.02 | 18320071 19208741 | |
| MESH:D001943 | Breast Neoplasms | Dietary Fats | 40.02 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 40.02 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 40.02 | 17129689 15324884 | |
| MESH:D001943 | Breast Neoplasms | Disulfiram | 40.02 | 17026967 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 40.02 | 18497071 17261762 14630087 16675129 12948864 19861407 17289903 17018787 | |
| MESH:D001943 | Breast Neoplasms | Etoposide | 40.02 | 16322251 | |
| MESH:D001943 | Breast Neoplasms | Fenretinide | 40.02 | 16601279 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 40.02 | 16541309 16873071 17200150 | |
| MESH:D001943 | Breast Neoplasms | indole-3-carbinol | 40.02 | 16082211 | |
| MESH:D001943 | Breast Neoplasms | LY 353381 | 40.02 | 19477949 | |
| MESH:D001943 | Breast Neoplasms | Methotrexate | 40.02 | 16978400 | |
| MESH:D001943 | Breast Neoplasms | Methylcholanthrene | 40.02 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Nickel | 40.02 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 40.02 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 40.02 | 17651959 16393696 17534123 | |
| MESH:D001943 | Breast Neoplasms | Styrene | 40.02 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 40.02 | 16642371 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 40.02 | 19410462 18984771 17049068 15565566 18821012 17242785 18997820 19189210 19011961 18351453 19244106 20544844 17893378 15668708 19487384 19289846 17440819 18629630 19059307 20065188 20859285 19115204 19066611 16202921 19200415 19155303 18815881 19189212 19288272 19142967 20390343 18425577 16818667 11161223 16873071 20005174 17261762 20135344 19103187 18855134 16273361 19084267 19221464 21138602 21152245 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 40.02 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 40.02 | 16873071 16443354 16166294 | |
| MESH:D001943 | Breast Neoplasms | Vanadium | 40.02 | 15565634 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 2.57 | 15516495 19059883 18315731 17626835 16777450 14754758 18417511 | |
| MESH:D001991 | Bronchitis | vanadium pentoxide | 4.88 | 17459161 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 3.26 | 16813970 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.06 | 11589617 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 3.99 | 9625245 | |
| MESH:D002100 | Cachexia | Ibuprofen | 8.16 | 15141370 | |
| MESH:D002100 | Cachexia | Ozone | 8.16 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.19 | 16962696 | |
| MESH:D002177 | Candidiasis | Disulfiram | 4.52 | 15325261 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.13 | 16111702 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 13.61 | 16192424 15721981 16097048 15700767 10355542 16011737 15673190 16124888 3786805 16050911 16227642 18705752 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Melatonin | 13.61 | 15700767 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Oleanolic Acid | 13.61 | 10355542 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 13.61 | 16050911 | |
| MESH:D002277 | Carcinoma | Curcumin | 14.21 | 18593918 | |
| MESH:D002277 | Carcinoma | Dimethylnitrosamine | 14.21 | 19555203 | |
| MESH:D002277 | Carcinoma | Disulfiram | 14.21 | 17026967 | |
| MESH:D002277 | Carcinoma | Methylcholanthrene | 14.21 | 10545420 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 14.21 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 2.66 | 15504454 17687452 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.19 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.80 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 47.51 | 16705839 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 47.51 | 16705839 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 47.51 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Aflatoxin B1 | 47.51 | 21507988 12907637 12619106 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 47.51 | 17306315 16507464 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 47.51 | 16217749 14691202 11135700 15073043 15553829 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 47.51 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 47.51 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 47.51 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 47.51 | 16569478 18978308 16502159 10737359 16540662 16681979 16328049 18665156 17138121 17162532 19171122 3581430 17055752 21159647 20214788 19394651 18210153 17978847 16935385 19822196 16288022 20524982 17173139 18785209 16698587 11831363 20727157 17428255 20514400 20007298 10672840 18056438 19701751 20084675 16830150 20101231 3084413 19107877 16878318 19383236 18393292 19519916 19919837 16779866 18788625 20935162 19052882 16807293 19539802 19418558 19208518 18691550 18494052 19335982 18971187 20432363 17761372 20512989 18506893 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 47.51 | 15948411 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 47.51 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethoxyquin | 47.51 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 47.51 | 17159502 16270382 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 47.51 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 47.51 | 17173139 6705139 1701930 20007298 20935162 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 47.51 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 47.51 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 47.51 | 19321006 16227395 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 47.51 | 16507464 17306315 15276417 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 47.51 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thioacetamide | 47.51 | 17997003 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 47.51 | 1917145 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Vanadium | 47.51 | 16830150 16878318 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 7.09 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 7.09 | 16675471 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | marker/mechanism | 9865924 | ||
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Carboplatin | 11.49 | 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 11.49 | 16685392 12023789 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 11.49 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Disulfiram | 11.49 | 17026967 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfide | 11.49 | 12391285 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfone | 11.49 | 18758305 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.64 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.52 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 4.46 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | ferric nitrilotriacetate | 4.46 | 8340253 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.90 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | 4-Nitroquinoline-1-oxide | 37.97 | 16543248 | |
| MESH:D002294 | Carcinoma, Squamous Cell | 9,10-Dimethyl-1,2-benzanthracene | 37.97 | 11376689 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 37.97 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 37.97 | 17687452 15504454 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 37.97 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 37.97 | 17066447 18337622 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 37.97 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 37.97 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 37.97 | 16033868 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 37.97 | 16274795 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 37.97 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 37.97 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 37.97 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 37.97 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 37.97 | 16096774 16051514 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 37.97 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 9.15 | 18640142 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Nitrofurantoin | 9.15 | 15028437 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 9.15 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Copper | 8.63 | 17327471 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 8.63 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 8.63 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 8.63 | 16120746 18670907 18850075 | |
| MESH:D009202 | Cardiomyopathies | Iron | 5.23 | 16640825 | |
| MESH:D009202 | Cardiomyopathies | pimagedine | 5.23 | 16612575 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Iron | 3.98 | 16604332 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Mercury | 3.98 | 10334427 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 18.13 | 15738583 19152805 17938729 | |
| MESH:D002318 | Cardiovascular Diseases | daidzein | 18.13 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 18.13 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 18.13 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | Isoflavones | 18.13 | 17689850 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 18.13 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 18.13 | 16936243 | |
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.12 | 16973168 18022660 | |
| MESH:D002386 | Cataract | 4-amino-2,6-dinitrotoluene | 16.39 | 14694615 | |
| MESH:D002386 | Cataract | Acetaminophen | 16.39 | 10977129 | |
| MESH:D002386 | Cataract | Disulfiram | 16.39 | 15003327 17936468 | |
| MESH:D002386 | Cataract | pimagedine | 16.39 | 15003327 17936468 | |
| MESH:D002386 | Cataract | Tretinoin | 16.39 | 17460283 | |
| MESH:D002386 | Cataract | Trinitrotoluene | 16.39 | 15817613 14694615 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 33.04 | 6135515 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 33.04 | 20889678 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 33.04 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cadmium | 33.04 | 17332340 | |
| MESH:D002471 | Cell Transformation, Neoplastic | cinnamic aldehyde | 33.04 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Clofibrate | 33.04 | 1399818 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 33.04 | 21159647 17174075 2727394 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 33.04 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylcholanthrene | 33.04 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | monomethylarsonous acid | 33.04 | 19716837 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 33.04 | 19524636 20056578 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Vanadium | 33.04 | 17174075 | |
| MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 2.95 | 4080065 | |
| MESH:D002547 | Cerebral Palsy | Toluene | 4.51 | 9294310 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 8.56 | 16154183 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 8.56 | 16129372 | |
| MESH:D018281 | Cholangiocarcinoma | 3,4,5,3',4'-pentachlorobiphenyl | 13.43 | 16628245 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 13.43 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 13.43 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thioacetamide | 13.43 | 18291259 | |
| MESH:D002761 | Cholangitis | 1-Naphthylisothiocyanate | 4.84 | 12912871 | |
| MESH:D002779 | Cholestasis | 1-Naphthylisothiocyanate | 7.17 | 16629650 18164287 15500046 18590720 7624871 19486331 12927374 15913567 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 7.17 | 17333356 17110522 16105132 16919318 11677210 17681005 15861022 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 7.17 | 19176532 | |
| MESH:D002780 | Cholestasis, Intrahepatic | 1-Naphthylisothiocyanate | 4.50 | 19407337 10220858 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.80 | 16461808 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 3.44 | 15894690 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 5.20 | 15668235 12621046 16354765 8697196 15340226 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 5.20 | 9407595 | |
| MESH:D002972 | Cleft Palate | triadimefon | 5.20 | 16781842 | |
| MESH:D019970 | Cocaine-Related Disorders | Disulfiram | 4.42 | 19462300 | |
| MESH:D003092 | Colitis | Curcumin | 12.35 | 16782535 16804969 18200517 | |
| MESH:D003092 | Colitis | resveratrol | 12.35 | 16474422 | |
| MESH:D003092 | Colitis | Selenium | 12.35 | 17936198 | |
| MESH:D003092 | Colitis | Tretinoin | 12.35 | 17035595 | |
| MESH:D003093 | Colitis, Ulcerative | Dinitrochlorobenzene | 4.22 | 17373747 19159591 | |
| MESH:D003093 | Colitis, Ulcerative | phenethyl isothiocyanate | 4.22 | 20423518 | |
| MESH:D003103 | Coloboma | Curcumin | 3.31 | 18809619 | |
| MESH:D003110 | Colonic Neoplasms | 17-(allylamino)-17-demethoxygeldanamycin | 31.54 | 15993848 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 31.54 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Butyrates | 31.54 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | cinnamic aldehyde | 31.54 | 17510524 16343908 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 31.54 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 31.54 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 31.54 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 31.54 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | irinotecan | 31.54 | 17287894 17725105 | |
| MESH:D003110 | Colonic Neoplasms | Iron | 31.54 | 16640825 | |
| MESH:D003110 | Colonic Neoplasms | nitroaspirin | 31.54 | 16818512 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 31.54 | 17148506 11134977 19440933 17191121 19056647 15741050 16640504 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 31.54 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | rofecoxib | 31.54 | 12902858 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 31.54 | 12902858 12458338 | |
| MESH:D003110 | Colonic Neoplasms | Vanadium | 31.54 | 18155637 | |
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 13.50 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 13.50 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | Azacitidine | 13.50 | 19934284 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 13.50 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 13.50 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Fenretinide | 13.50 | 17273769 | |
| MESH:D015179 | Colorectal Neoplasms | irinotecan | 13.50 | 16391804 16303861 17159606 18509181 15273666 18259882 17454858 | |
| MESH:D015179 | Colorectal Neoplasms | Isoflavones | 13.50 | 17116718 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 13.50 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 13.50 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 13.50 | 11197048 10666051 11076880 18059344 | |
| MESH:D015179 | Colorectal Neoplasms | sulindac sulfone | 13.50 | 10666051 10416599 11197048 18059344 | |
| MESH:D003139 | Common Cold | Ascorbic Acid | 4.12 | 17323712 | |
| MESH:D000013 | Congenital Abnormalities | 2-amino-4,6-dinitrotoluene | 12.60 | 15095906 | |
| MESH:D000013 | Congenital Abnormalities | 4-amino-2,6-dinitrotoluene | 12.60 | 15095906 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 12.60 | 17141729 14669216 | |
| MESH:D000013 | Congenital Abnormalities | Trinitrotoluene | 12.60 | 15095906 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 3.59 | 18497527 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.74 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.90 | 12609071 | |
| MESH:D019465 | Craniofacial Abnormalities | 3,4,5,3',4'-pentachlorobiphenyl | 17.04 | 17686920 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 17.04 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Benzene | 17.04 | 15643154 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 17.04 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Lead | 17.04 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Methotrexate | 17.04 | 9562676 12039119 | |
| MESH:D019465 | Craniofacial Abnormalities | sodium arsenate | 17.04 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 17.04 | 15322242 10048152 20055451 | |
| MESH:D019465 | Craniofacial Abnormalities | Toluene | 17.04 | 9294310 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 17.04 | 9125849 17551590 14991402 10589399 9211117 16925845 9224671 8800419 9142499 9664655 | |
| MESH:D019465 | Craniofacial Abnormalities | triadimefon | 17.04 | 15834900 16875885 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 17.04 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 17.04 | 19302082 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 3.27 | 12952375 16002989 | |
| MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 11.31 | 18551238 | |
| MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 11.31 | 18551238 | |
| MESH:D003490 | Cyanosis | Trinitrotoluene | 11.31 | 18551238 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 7.69 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 7.69 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Methotrexate | 7.69 | 19747007 | |
| MESH:D003556 | Cystitis | Acrolein | 7.63 | 12161096 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 7.63 | 17979934 18483878 15276878 18093676 12388444 16614059 18372110 18295254 10700343 12161096 12913760 16651033 16413132 18710439 18433785 17010015 15643279 10498854 11948286 16989017 | |
| MESH:D003643 | Death | Toluene | 4.32 | 6431079 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 2.84 | 15213294 | |
| MESH:D003704 | Dementia | Lead | 4.03 | 16140633 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.05 | 19031437 | |
| MESH:D003715 | Dengue | F2-Isoprostanes | 5.34 | 19427377 | |
| MESH:D003872 | Dermatitis | Benzene | 3.46 | 15902427 | |
| MESH:D017449 | Dermatitis, Allergic Contact | 4-phenylenediamine | 13.73 | 11906362 16533241 16823706 19470301 18759875 11298694 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cinnamic aldehyde | 13.73 | 11042091 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 13.73 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dinitrochlorobenzene | 13.73 | 15491423 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Mercury | 13.73 | 16823706 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Nickel | 13.73 | 17100760 19470301 17244072 | |
| MESH:D017449 | Dermatitis, Allergic Contact | nickel sulfate | 13.73 | 16823706 16780908 11298694 | |
| MESH:D003876 | Dermatitis, Atopic | Diethylhexyl Phthalate | 4.12 | 16882537 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 4.12 | 18249437 | |
| MESH:D003877 | Dermatitis, Contact | 4-phenylenediamine | 6.09 | 11531941 | |
| MESH:D003877 | Dermatitis, Contact | Nickel | 6.09 | 2952479 | |
| MESH:D003882 | Dermatomyositis | Methotrexate | 3.84 | 20191521 | |
| MESH:D018500 | Diabetes Insipidus, Nephrogenic | 17-(allylamino)-17-demethoxygeldanamycin | 4.94 | 18854434 | |
| MESH:D003920 | Diabetes Mellitus | Iron | 8.71 | 16640825 16604332 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 8.71 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 8.71 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 7.39 | 10990075 15331540 11751995 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 7.39 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 7.39 | 16873680 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 3.74 | 18772604 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 3.74 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Ascorbic Acid | 13.96 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | coumarin | 13.96 | 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 13.96 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | daidzein | 13.96 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 13.96 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 13.96 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 13.96 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 13.96 | 17107852 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 15.70 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 15.70 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 15.70 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 15.70 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 15.70 | 19279558 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 3.89 | 17621415 12861449 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 2.53 | 7237001 | |
| MESH:D056486 | Drug-Induced Liver Injury | 1,2,4-trichlorobenzene | 63.58 | 10092053 | |
| MESH:D056486 | Drug-Induced Liver Injury | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | 63.58 | 19371629 | |
| MESH:D056486 | Drug-Induced Liver Injury | 1-Naphthylisothiocyanate | 63.58 | 18289764 17522070 20133375 7624871 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 63.58 | 18551238 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 63.58 | 18551238 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2-amino-4,6-dinitrotoluene | 63.58 | 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | 4-amino-2,6-dinitrotoluene | 63.58 | 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 63.58 | 11287661 17562736 11421492 14550746 11461765 17906064 10915739 16393943 16177239 12594235 16081117 16485898 12392966 11743745 14725611 11739529 15619225 12540782 12958197 19420014 15968718 2444490 10774834 19923254 16109766 18713872 19739265 19370779 19085960 12153990 11834606 10663392 17522070 11529661 12705907 19164858 18071297 16227642 19416960 14986274 16781746 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 63.58 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | allyl sulfide | 63.58 | 15950962 | |
| MESH:D056486 | Drug-Induced Liver Injury | bromobenzene | 63.58 | 10092053 12628495 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 63.58 | 15998439 19085960 19336974 7440962 4309450 15968718 11566570 21278145 3786805 16227642 7179309 10915739 15027814 2869522 6884620 16177239 7120509 10092053 3732212 9327722 17522070 6623471 | |
| MESH:D056486 | Drug-Induced Liver Injury | Chlorodiphenyl (54% Chlorine) | 63.58 | 17851650 | |
| MESH:D056486 | Drug-Induced Liver Injury | cyanoginosin LR | 63.58 | 17654400 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 63.58 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 63.58 | 8172417 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diquat | 63.58 | 18445702 18164269 | |
| MESH:D056486 | Drug-Induced Liver Injury | Nitrofurantoin | 63.58 | 1551546 19789166 19214031 8373174 | |
| MESH:D056486 | Drug-Induced Liver Injury | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate | 63.58 | 12540782 | |
| MESH:D056486 | Drug-Induced Liver Injury | pyrazole | 63.58 | 12499123 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 63.58 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | sodium arsenate | 63.58 | 18186108 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 63.58 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 63.58 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetracycline | 63.58 | 17522070 | |
| MESH:D056486 | Drug-Induced Liver Injury | Thioacetamide | 63.58 | 12963478 | |
| MESH:D056486 | Drug-Induced Liver Injury | Trinitrotoluene | 63.58 | 21346803 18551238 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.75 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 4.53 | 12231392 19839026 15033597 12649298 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 4.53 | 11462148 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Ibuprofen | 4.28 | 18450898 18446180 16133044 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 2.81 | 17351913 | |
| MESH:D050171 | Dyslipidemias | Clofibrate | 5.20 | 16707586 | |
| MESH:D050171 | Dyslipidemias | Dietary Fats | 5.20 | 18367378 | |
| MESH:D004421 | Dystonia | Phenobarbital | 2.75 | 1851702 | |
| MESH:C538011 | Eales disease | Ascorbic Acid | 8.60 | 9068938 | |
| MESH:C538011 | Eales disease | Vitamin E | 8.60 | 9068938 | |
| MESH:D004485 | Eczema | Dexamethasone | 3.19 | 12438553 | |
| MESH:D004487 | Edema | bis(4-hydroxycinnamoyl)methane | 27.11 | 18449507 | |
| MESH:D004487 | Edema | demethoxycurcumin | 27.11 | 18449507 | |
| MESH:D004487 | Edema | Dexamethasone | 27.11 | 19703484 | |
| MESH:D004487 | Edema | Diclofenac | 27.11 | 16273134 | |
| MESH:D004487 | Edema | perfluorooctanoic acid | 27.11 | 12083418 17259670 | |
| MESH:D004487 | Edema | phenidone | 27.11 | 7990266 | |
| MESH:D004487 | Edema | pirinixic acid | 27.11 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 27.11 | 12787963 | |
| MESH:D004487 | Edema | resveratrol | 27.11 | 8985016 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 27.11 | 11000095 12711302 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 27.11 | 9599246 8113982 8273558 16716910 15177302 11698051 7812673 | |
| MESH:D004489 | Edema, Cardiac | 3,4,5,3',4'-pentachlorobiphenyl | 13.37 | 17686920 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 13.37 | 18230668 16714409 15322242 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 13.37 | 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 8.06 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 8.06 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 8.06 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 3.76 | 19294695 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 7.49 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 7.49 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | daidzein | 15.88 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 15.88 | 16804899 15700306 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 15.88 | 18566989 11473722 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 15.88 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 15.88 | 17893378 16202921 19155303 20544844 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 15.88 | 16569247 | |
| MESH:D004715 | Endometriosis | Ibuprofen | 16.05 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 16.05 | 16134523 | |
| MESH:D004715 | Endometriosis | rofecoxib | 16.05 | 15652904 | |
| MESH:D004715 | Endometriosis | Sulindac | 16.05 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 16.05 | 10568697 9294722 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 4.33 | 15268973 | |
| MESH:D019446 | Endotoxemia | Ibuprofen | 6.45 | 11545620 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 6.45 | 15821434 15328337 17637181 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 3.54 | 17923197 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 2.97 | 11006010 | |
| MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 2.81 | 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Phenobarbital | 2.55 | 3922381 11558140 | |
| MESH:D004827 | Epilepsy | Phenobarbital | 3.98 | 20417680 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 3.98 | 19439326 19700373 | |
| MESH:D004832 | Epilepsy, Absence | Phenobarbital | 2.38 | 6401628 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 2.95 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 2.71 | 3659116 | |
| MESH:D007172 | Erectile Dysfunction | daidzein | 3.75 | 14972507 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.76 | 16302075 | |
| MESH:D004938 | Esophageal Neoplasms | 4-Nitroquinoline-1-oxide | 14.04 | 16543248 | |
| MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 14.04 | 20426865 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 14.04 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 14.04 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 14.04 | 16481741 15173087 17638652 15464296 16785472 | |
| MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 14.04 | 17016578 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 14.04 | 12235107 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 14.04 | 16543248 | |
| MESH:D020329 | Essential Tremor | Lead | 4.60 | 14594619 18007985 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 5.13 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 5.13 | 16938888 9664655 | |
| MESH:D005218 | Fat Necrosis | Thioacetamide | 4.36 | 16456712 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 42.55 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 42.55 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 42.55 | 19224547 17595544 15959796 16045604 12795759 16239168 12631006 61145 | |
| MESH:D005234 | Fatty Liver | Clofibrate | 42.55 | 19224547 | |
| MESH:D005234 | Fatty Liver | Curcumin | 42.55 | 19297423 | |
| MESH:D005234 | Fatty Liver | Dietary Fats | 42.55 | 18296743 19551842 17967931 19004024 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 42.55 | 20387270 21071580 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 42.55 | 15345470 | |
| MESH:D005234 | Fatty Liver | Iron | 42.55 | 16640825 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 42.55 | 20131406 19236843 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 42.55 | 15975614 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 42.55 | 14986274 19224547 | |
| MESH:D005234 | Fatty Liver | Tetracycline | 42.55 | 19224547 16917069 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 4.88 | 16534752 16611131 15751030 16513791 16002989 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 4.88 | 16709447 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.16 | 11858732 | |
| MESH:D005317 | Fetal Growth Retardation | 1,2,4-trichlorobenzene | 7.78 | 6884296 | |
| MESH:D005317 | Fetal Growth Retardation | Lead | 7.78 | 19769572 | |
| MESH:D005334 | Fever | Ibuprofen | 5.54 | 16997862 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 5.54 | 11852909 9205823 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 8.54 | 14745880 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 8.54 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 7.24 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 7.24 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Methylcholanthrene | 3.61 | 14633661 10962813 | |
| MESH:D005355 | Fibrosis | arsenite | 22.14 | 18296743 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 22.14 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 22.14 | 18705752 | |
| MESH:D005355 | Fibrosis | Dietary Fats | 22.14 | 18296743 | |
| MESH:D005355 | Fibrosis | Quercetin | 22.14 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 22.14 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 22.14 | 17994277 | |
| MESH:D005534 | Foot Diseases | Arsenic | 4.20 | 6392382 | |
| MESH:D005621 | Friedreich Ataxia | Iron | 4.11 | 16604332 16640825 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 2.98 | 16904648 | |
| MESH:D005756 | Gastritis | Acetaminophen | 11.47 | 16983495 | |
| MESH:D005756 | Gastritis | Diquat | 11.47 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 11.47 | 17241300 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 3.73 | 11910360 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.39 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 8.40 | 16452187 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 8.40 | 16452187 | |
| MESH:D005909 | Glioblastoma | Curcumin | 14.59 | 17596214 | |
| MESH:D005909 | Glioblastoma | Fenretinide | 14.59 | 16187019 | |
| MESH:D005909 | Glioblastoma | Genistein | 14.59 | 16598420 | |
| MESH:D005909 | Glioblastoma | perfluorooctane sulfonic acid | 14.59 | 17162496 | |
| MESH:D005909 | Glioblastoma | Quercetin | 14.59 | 19804834 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 14.59 | 17312396 | |
| MESH:D005910 | Glioma | Quercetin | 2.35 | 17643826 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 4.18 | 11389073 | |
| MESH:D005911 | Gliosis | Paraquat | 3.81 | 11124998 | |
| MESH:D018149 | Glucose Intolerance | sodium arsenate | 3.82 | 19446573 | |
| MESH:D006030 | Glycosuria, Renal | Mercuric Chloride | 4.59 | 2918855 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.24 | 10696789 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 7.83 | 11014644 15172196 16376943 | |
| MESH:D006086 | Graft vs Host Disease | Methotrexate | 7.83 | 16518429 | |
| MESH:D006130 | Growth Disorders | Zinc | 2.95 | 17217573 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 9.90 | 15464296 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 9.90 | 18462866 18829502 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 9.90 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 9.90 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 6.52 | 19898482 | |
| MESH:D034381 | Hearing Loss | Styrene | 6.52 | 17420221 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.80 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.24 | 15464296 | |
| MESH:D006330 | Heart Defects, Congenital | 2,3,7,8-tetrachlorodibenzofuran | 17.70 | 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | 3,4,5,3',4'-pentachlorobiphenyl | 17.70 | 20471113 17686920 | |
| MESH:D006330 | Heart Defects, Congenital | Ascorbic Acid | 17.70 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 17.70 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 17.70 | 11294989 10048152 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 17.70 | 14991402 9664655 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin E | 17.70 | 16080930 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 8.74 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 8.74 | 18097624 | |
| MESH:D006333 | Heart Failure | Selenium | 8.74 | 17162251 | |
| MESH:D006333 | Heart Failure | Zinc | 8.74 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.41 | 17074742 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 3.28 | 17241300 | |
| MESH:D006402 | Hematologic Diseases | Benzene | 3.40 | 16183116 | |
| MESH:D006432 | Hemochromatosis | Iron | 3.40 | 16640825 16574947 16604332 17236123 17053826 17255318 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.17 | 16366002 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 3.98 | 11918545 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.11 | 11000095 | |
| MESH:D006486 | Hemosiderosis | Iron | 3.87 | 16604332 | |
| MESH:D006501 | Hepatic Encephalopathy | Thioacetamide | 3.34 | 15929193 18665440 17276928 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 4.18 | 14986274 | |
| MESH:D006505 | Hepatitis | 1-Naphthylisothiocyanate | 8.57 | 18590720 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 8.57 | 19110552 19900420 | |
| MESH:D006505 | Hepatitis | Thioacetamide | 8.57 | 16456712 | |
| MESH:D006521 | Hepatitis, Chronic | Copper | 11.85 | 17338147 | |
| MESH:D006521 | Hepatitis, Chronic | Diclofenac | 11.85 | 14986274 | |
| MESH:D006521 | Hepatitis, Chronic | Nitrofurantoin | 11.85 | 14986274 | |
| MESH:D006525 | Hepatitis, Viral, Human | allyl sulfide | 9.19 | 15950962 | |
| MESH:D006525 | Hepatitis, Viral, Human | Iron | 9.19 | 16640825 | |
| MESH:D006527 | Hepatolenticular Degeneration | Copper | 11.16 | 19888908 17276780 16607473 17109627 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Iron | 11.16 | 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 11.16 | 17276780 | |
| MESH:D006529 | Hepatomegaly | Iron | 29.55 | 16890145 | |
| MESH:D006529 | Hepatomegaly | perfluorooctanoic acid | 29.55 | 3609246 | |
| MESH:D006529 | Hepatomegaly | Phenobarbital | 29.55 | 16109766 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 29.55 | 18467677 16221962 19772884 19176532 | |
| MESH:D006529 | Hepatomegaly | propiconazole | 29.55 | 17178689 17178688 | |
| MESH:D006529 | Hepatomegaly | systhane | 29.55 | 17178688 17178689 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 29.55 | 12621046 15340226 16120746 | |
| MESH:D006529 | Hepatomegaly | triadimefon | 29.55 | 17178688 17178689 | |
| MESH:D006529 | Hepatomegaly | Trinitrotoluene | 29.55 | 15817613 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.73 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Ascorbic Acid | 5.39 | 16863852 16490937 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 5.39 | 7520565 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 5.39 | 16490937 16863852 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.67 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Etoposide | 9.01 | 10809021 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 9.01 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 9.01 | 16876885 | |
| MESH:D015658 | HIV Infections | Iron | 5.78 | 16597321 | |
| MESH:D015658 | HIV Infections | Nickel | 5.78 | 17263646 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 5.78 | 12878215 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 8.09 | 16170182 16200630 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 8.09 | 16135485 17606976 | |
| MESH:D006689 | Hodgkin Disease | Etoposide | 8.09 | 16200630 17606976 15147373 18180244 16135485 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 8.09 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 13.57 | 17088409 | |
| MESH:D019584 | Hot Flashes | Isoflavones | 13.57 | 14716179 17290160 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 13.57 | 17454163 16566672 14716179 | |
| MESH:D019584 | Hot Flashes | Vitamin E | 13.57 | 14716179 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.69 | 15340226 8697196 16354765 18606429 16959395 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 6.56 | 16870215 | |
| MESH:D006930 | Hyperalgesia | perfluorooctanoic acid | 6.56 | 12083418 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 6.56 | 16870215 | |
| MESH:D017588 | Hyperandrogenism | Flutamide | 4.12 | 15356085 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.20 | 16899240 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 8.31 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | Dietary Fats | 8.31 | 21332399 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 8.31 | 17188708 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.25 | 16778211 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 5.24 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 5.24 | 11834736 18262572 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 3.29 | 16484555 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.24 | 17050553 | |
| MESH:D006949 | Hyperlipidemias | Dietary Fats | 11.96 | 21332399 | |
| MESH:D006949 | Hyperlipidemias | Oleanolic Acid | 11.96 | 8847885 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 11.96 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 11.96 | 16873680 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 3.14 | 14722030 12960047 | |
| MESH:D006967 | Hypersensitivity | Butylated Hydroxytoluene | 3.34 | 17604070 | |
| MESH:D006973 | Hypertension | Arsenic | 10.60 | 11953799 9931084 16076760 | |
| MESH:D006973 | Hypertension | Benzene | 10.60 | 17940673 | |
| MESH:D006973 | Hypertension | daidzein | 10.60 | 17169123 | |
| MESH:D006973 | Hypertension | Dexamethasone | 10.60 | 17042910 | |
| MESH:D006973 | Hypertension | Quercetin | 10.60 | 18356687 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 10.60 | 18850075 18670907 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 2.79 | 15338365 | |
| MESH:D006984 | Hypertrophy | Ibuprofen | 3.74 | 16672835 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 3.09 | 17488730 | |
| MESH:D006987 | Hypesthesia | Arsenic | 4.20 | 16093927 | |
| MESH:D007006 | Hypogonadism | Iron | 3.33 | 16640825 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 6.91 | 16002989 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 6.91 | 16945680 16569931 | |
| MESH:D007037 | Hypothyroidism | Iron | 3.78 | 16640825 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 3.98 | 16076520 | |
| MESH:D007235 | Infant, Premature, Diseases | Ibuprofen | 4.48 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 3.34 | 17600658 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 3.08 | 15036965 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.21 | 12013081 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 19.33 | 7193160 16517039 | |
| MESH:D007248 | Infertility, Male | decitabine | 19.33 | 17581917 | |
| MESH:D007248 | Infertility, Male | Diquat | 19.33 | 4850670 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 19.33 | 17937319 | |
| MESH:D007248 | Infertility, Male | Lead | 19.33 | 16780224 | |
| MESH:D007248 | Infertility, Male | Paraquat | 19.33 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 19.33 | 12646999 15346721 | |
| MESH:D007248 | Infertility, Male | Trinitrotoluene | 19.33 | 12150543 | |
| MESH:D007249 | Inflammation | Curcumin | 41.54 | 16956363 17151092 18403477 | |
| MESH:D007249 | Inflammation | Dexamethasone | 41.54 | 11099482 8960868 | |
| MESH:D007249 | Inflammation | Diclofenac | 41.54 | 16273134 | |
| MESH:D007249 | Inflammation | Dietary Fats | 41.54 | 20412841 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 41.54 | 18785209 | |
| MESH:D007249 | Inflammation | Flavonoids | 41.54 | 17296493 | |
| MESH:D007249 | Inflammation | Flurbiprofen | 41.54 | 11099482 | |
| MESH:D007249 | Inflammation | Ibuprofen | 41.54 | 3291741 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 41.54 | 17963957 12878042 17255318 9205823 17237260 | |
| MESH:D007249 | Inflammation | Nickel | 41.54 | 16166738 | |
| MESH:D007249 | Inflammation | Oleanolic Acid | 41.54 | 8847885 | |
| MESH:D007249 | Inflammation | perfluorooctanoic acid | 41.54 | 12083418 | |
| MESH:D007249 | Inflammation | Plant Extracts | 41.54 | 15997105 12787963 16366677 19332304 | |
| MESH:D007249 | Inflammation | resveratrol | 41.54 | 16366677 | |
| MESH:D007249 | Inflammation | Sulindac | 41.54 | 3291741 | |
| MESH:D007249 | Inflammation | Tamoxifen | 41.54 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 41.54 | 12200463 12878042 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 41.54 | 11698051 7812673 15177302 8273558 7562506 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 2.48 | 18200517 18596194 | |
| MESH:D007251 | Influenza, Human | Quercetin | 15.76 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 15.76 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 15.76 | 16624496 | |
| MESH:D007251 | Influenza, Human | Vitamin E | 15.76 | 16624496 | |
| MESH:D007333 | Insulin Resistance | Dietary Fats | 9.20 | 11836018 18457598 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 9.20 | 16627594 16393666 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 9.20 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 9.20 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | pimagedine | 9.30 | 11713966 | |
| MESH:D007410 | Intestinal Diseases | rofecoxib | 9.30 | 15831440 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 9.30 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 9.58 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 9.58 | 12628509 12584176 12351151 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 9.58 | 12628509 12663524 12584176 10213222 12351151 10223192 | |
| MESH:D007417 | Intestinal Polyps | rofecoxib | 7.45 | 11245490 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 7.45 | 11245490 12394442 | |
| MESH:D019189 | Iron Metabolism Disorders | Iron | 7.41 | 17163184 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 7.41 | 17255318 | |
| MESH:D007511 | Ischemia | Zinc | 3.34 | 16584753 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 10.15 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 10.15 | 17551590 15992940 | |
| MESH:D007569 | Jaw Abnormalities | triadimefon | 10.15 | 15992940 15834900 | |
| MESH:D007627 | Keloid | Quercetin | 3.64 | 17086741 | |
| MESH:D007642 | Keratosis | Arsenic | 3.66 | 16930632 12749816 | |
| MESH:D055623 | Keratosis, Actinic | Phenol | 5.09 | 19293009 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 3.79 | 15464296 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 33.61 | 15629191 12587719 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 33.61 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Cadmium | 33.61 | 16322080 16226777 16962696 | |
| MESH:D007674 | Kidney Diseases | Cadmium Chloride | 33.61 | 16962696 | |
| MESH:D007674 | Kidney Diseases | Chromium | 33.61 | 17934191 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 33.61 | 19839026 12649298 15190930 18289764 12231392 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 33.61 | 15618244 | |
| MESH:D007674 | Kidney Diseases | ferric nitrilotriacetate | 33.61 | 18617210 15834431 | |
| MESH:D007674 | Kidney Diseases | Mercury | 33.61 | 17934191 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 33.61 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 33.61 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Vitamin E | 33.61 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Zinc | 33.61 | 16960431 | |
| MESH:D007676 | Kidney Failure, Chronic | Copper | 13.87 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 13.87 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 13.87 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 13.87 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 14.44 | 16705839 | |
| MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 14.44 | 16705839 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 14.44 | 15003126 16762066 14681315 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 14.44 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | ferric nitrilotriacetate | 14.44 | 18055543 9667754 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 14.44 | 18625569 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 3.45 | 11231351 | |
| MESH:D007805 | Language Development Disorders | Methotrexate | 3.84 | 9562676 | |
| MESH:D007855 | Lead Poisoning | Lead | 4.60 | 16700817 | |
| MESH:D007859 | Learning Disorders | Copper | 8.93 | 17134702 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 8.93 | 17184923 | |
| MESH:D007859 | Learning Disorders | Lead | 8.93 | 16384672 | |
| MESH:D007889 | Leiomyoma | Curcumin | 3.31 | 18555241 | |
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 26.16 | 12970779 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 26.16 | 15070760 | |
| MESH:D007938 | Leukemia | Azacitidine | 26.16 | 19148494 | |
| MESH:D007938 | Leukemia | Benzene | 26.16 | 18335105 17119257 14694614 15935818 | |
| MESH:D007938 | Leukemia | Curcumin | 26.16 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 26.16 | 10602166 | |
| MESH:D007938 | Leukemia | decitabine | 26.16 | 19235587 18980019 | |
| MESH:D007938 | Leukemia | Genistein | 26.16 | 17468513 18980019 | |
| MESH:D007938 | Leukemia | Quercetin | 26.16 | 17468513 | |
| MESH:D007938 | Leukemia | Tretinoin | 26.16 | 17143497 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 4.42 | 17802794 18587576 17296974 18172266 17008537 17658394 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Disulfiram | 4.42 | 17026967 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 5.69 | 17077332 12560223 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 5.69 | 16106398 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 7.33 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 7.33 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 4.96 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 4.96 | 10373061 | |
| MESH:D007951 | Leukemia, Myeloid | marker/mechanism | 11882782 | ||
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 17.06 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Azacitidine | 17.06 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Benzene | 17.06 | 17506065 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 17.06 | 17236224 19117987 18454857 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 17.06 | 16932348 19285840 16482212 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 6.22 | 17050201 16467208 16968895 19850784 20471514 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 6.22 | 17596541 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Benzene | 6.22 | 19478238 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 6.22 | 18206229 19010910 18704418 17679729 19387464 18460780 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 6.22 | 16294345 19850784 17596541 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 4.10 | 18055864 | |
| MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 3.92 | 19299654 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 9.73 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 9.73 | 16331271 19035177 12679006 19642359 11161223 16330433 15336539 17649720 17217047 16112521 19225113 19075265 12018890 15213294 17869043 9834237 15622746 12712474 16966277 17712046 16823087 16891316 15748426 17107899 11468182 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 9.73 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 9.73 | 17361223 16935935 16140955 17217047 19075265 12679006 17649720 19225113 17339181 17301526 16788101 16766008 19642359 19029980 17294898 16331271 19035177 17506722 16891316 17368321 17712046 15748426 9834237 17107899 16823087 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 7.45 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 7.45 | 16106398 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 7.37 | 11830472 10052129 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 7.37 | 15821434 | |
| MESH:D007972 | Leukoplakia, Oral | Fenretinide | 4.69 | 16707609 | |
| MESH:D020961 | Lewy Body Disease | Iron | 4.11 | 16563566 | |
| MESH:D007984 | Leydig Cell Tumor | perfluorooctanoic acid | 3.90 | 8812269 | |
| MESH:D017880 | Limb Deformities, Congenital | Disulfiram | 5.05 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 5.05 | 9224671 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 2.12 | 15342952 17567588 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 20.28 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 20.28 | 16239168 11408273 21278145 16943688 17174718 17157831 17334410 11903743 16221502 | |
| MESH:D008103 | Liver Cirrhosis | Dietary Fats | 20.28 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 20.28 | 18407596 18522880 19638242 18665156 20032147 | |
| MESH:D008103 | Liver Cirrhosis | Iron | 20.28 | 16640825 | |
| MESH:D008103 | Liver Cirrhosis | Methotrexate | 20.28 | 14986274 | |
| MESH:D008103 | Liver Cirrhosis | Phenobarbital | 20.28 | 21047994 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 20.28 | 17157831 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 3.23 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 29.41 | 15673190 17631135 14748882 17944888 17805973 18279442 12898905 16097048 12632514 18205269 14716496 18187930 17481882 12609069 12586293 15362042 18472332 16027843 17557913 17565644 17869086 12667390 18251166 12632512 17761835 16638106 17708605 15893842 15730626 18263696 12649538 11481614 15818738 15931870 18472094 14724832 18376398 18481824 18277467 16011737 12958196 18156304 18395914 18006644 12741479 18429990 18210741 18395095 16015684 18166357 17714472 14620537 16248980 17900296 15996030 12445421 12546737 18418968 12666154 15123356 16136751 15057751 17823541 14512876 18412020 12445418 15338365 17976157 20821823 15925388 12389079 17525996 18705752 16116963 13678700 17721639 18420326 17766677 10355542 18339082 17922224 18054572 15052691 16033810 15650968 15876570 15959796 14716833 17698563 18317297 15370692 17640975 16192424 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 29.41 | 17355460 18006644 18705752 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 29.41 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 29.41 | 17036385 18239293 15571005 15723089 15492853 15369754 17666798 16570917 15942678 15161499 15086199 17196135 17465448 17198567 15383259 16169303 14659978 18371158 17432682 16627068 15763062 16603200 15479170 17203207 17640959 15798949 17724770 15793283 17348192 17534399 16270385 18637143 18364076 14643895 15081153 12925901 15339415 15842777 18237412 18629640 18210741 15504291 15864749 15577212 17201889 18567088 17881167 12918455 16009107 15366600 14568256 15298665 15067225 14726149 18672772 16544323 17719030 15591649 14709902 15744066 18095165 15733078 16042886 15138612 15099470 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 29.41 | 14659978 14716833 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | F2-Isoprostanes | 29.41 | 16127424 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 29.41 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 29.41 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Melatonin | 29.41 | 15925388 16703270 15298665 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Oleanolic Acid | 29.41 | 10355542 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | oltipraz | 29.41 | 16544323 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 29.41 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 29.41 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 29.41 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | rofecoxib | 29.41 | 17565644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 29.41 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 29.41 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thioacetamide | 29.41 | 15474484 12891558 11682029 18416461 15316131 15334695 11172339 12679928 15288472 11481614 15158331 14739098 16343077 15288473 18031379 16126171 17629604 15075984 15465738 16511523 15716488 15078482 17292413 16489207 16248980 15362042 18380797 12557150 18458672 16098781 18295389 18395095 18032466 12085344 17355460 12531686 15095483 17050028 10677585 18606216 17127702 18615449 16097051 18263696 12175628 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 29.41 | 18397230 16248980 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 29.41 | 16169303 | |
| MESH:D008107 | Liver Diseases | marker/mechanism | 17405841 16610002 | ||
| MESH:D008107 | Liver Diseases | 1,2,4-trichlorobenzene | 33.02 | 1949037 | |
| MESH:D008107 | Liver Diseases | 1-Naphthylisothiocyanate | 33.02 | 17184895 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 33.02 | 19784758 19014921 16610002 19460945 12587719 12969438 16611625 11587558 | |
| MESH:D008107 | Liver Diseases | Arsenic | 33.02 | 11134558 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 33.02 | 16964402 16246199 15830285 15720792 17285989 | |
| MESH:D008107 | Liver Diseases | Curcumin | 33.02 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diclofenac | 33.02 | 14566034 16867024 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 33.02 | 17034775 | |
| MESH:D008107 | Liver Diseases | Nitrofurantoin | 33.02 | 14966256 | |
| MESH:D008107 | Liver Diseases | Oleanolic Acid | 33.02 | 8847885 15720792 | |
| MESH:D008107 | Liver Diseases | Phenobarbital | 33.02 | 19363144 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 33.02 | 17034775 | |
| MESH:D008107 | Liver Diseases | propiconazole | 33.02 | 19363144 | |
| MESH:D008107 | Liver Diseases | Sulindac | 33.02 | 14986274 16867024 | |
| MESH:D008107 | Liver Diseases | Thioacetamide | 33.02 | 16337175 15158337 18374380 | |
| MESH:D008107 | Liver Diseases | triadimefon | 33.02 | 19363144 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Iron | 3.70 | 16737972 17207112 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 2.86 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 13.42 | 16871587 17185352 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 13.42 | 14706259 16899240 | |
| MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 13.42 | 17457977 | |
| MESH:D017114 | Liver Failure, Acute | Thioacetamide | 13.42 | 15633222 17276928 12479984 15313186 | |
| MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 99.16 | 7678174 | |
| MESH:D008113 | Liver Neoplasms | 2-nitrofluorene | 99.16 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 99.16 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 99.16 | 9643874 | |
| MESH:D008113 | Liver Neoplasms | Aflatoxin B1 | 99.16 | 9163691 18177683 15890375 2125692 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 99.16 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 99.16 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 99.16 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 99.16 | 21295105 19389873 | |
| MESH:D008113 | Liver Neoplasms | Butylated Hydroxytoluene | 99.16 | 18177683 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 99.16 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | ciprofibrate | 99.16 | 12771043 | |
| MESH:D008113 | Liver Neoplasms | Copper | 99.16 | 20302851 | |
| MESH:D008113 | Liver Neoplasms | Diethylhexyl Phthalate | 99.16 | 11940454 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 99.16 | 12112319 19073162 19690152 19638242 19996281 10737359 20101389 2422723 15175105 20405173 19254457 19427195 18648771 21167192 18644402 19642983 12771043 16942905 20137499 20118626 19255062 19850985 19426721 19090486 20583210 2862719 19294768 19833225 18754104 9163691 18977376 15885732 19256749 20452335 19551842 21278145 20492335 21071580 20501860 20434301 21047994 18978307 19499222 19812893 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 99.16 | 16712894 15890375 | |
| MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 99.16 | 15890375 3113478 | |
| MESH:D008113 | Liver Neoplasms | Iron | 99.16 | 20302851 16640825 | |
| MESH:D008113 | Liver Neoplasms | Methapyrilene | 99.16 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | Mitomycin | 99.16 | 15113037 | |
| MESH:D008113 | Liver Neoplasms | oxfendazole | 99.16 | 18754104 | |
| MESH:D008113 | Liver Neoplasms | perfluorooctanoic acid | 99.16 | 18709148 14757943 | |
| MESH:D008113 | Liver Neoplasms | Phenobarbital | 99.16 | 21047994 8742319 19482888 19073162 19812893 15975961 | |
| MESH:D008113 | Liver Neoplasms | Piperonyl Butoxide | 99.16 | 15890375 20101389 19690152 18648771 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 99.16 | 15890375 20007298 16377806 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 99.16 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | propiconazole | 99.16 | 19028983 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 99.16 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 99.16 | 20405173 19812893 19321006 19073162 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 99.16 | 16712894 15276417 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 99.16 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 99.16 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | triadimefon | 99.16 | 19028983 | |
| MESH:D008113 | Liver Neoplasms | zerumbone | 99.16 | 20452335 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 49.20 | 2876784 2876786 6135515 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 9,10-Dimethyl-1,2-benzanthracene | 49.20 | 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Aflatoxin B1 | 49.20 | 8603461 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 49.20 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Ascorbic Acid | 49.20 | 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Benzene | 49.20 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 49.20 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 49.20 | 12014681 15583823 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 49.20 | 19519916 3124819 19539802 17174075 18282651 19004024 16267830 18308698 19009564 2563599 17942915 16842330 19126423 21159647 18164116 18079962 17854601 18093689 18775883 9362446 18253720 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 49.20 | 6150874 1848544 15603536 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Methylcholanthrene | 49.20 | 598648 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 49.20 | 18308698 1399818 17172636 6150874 2563599 | |
| MESH:D008114 | Liver Neoplasms, Experimental | propiconazole | 49.20 | 17178689 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 49.20 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | systhane | 49.20 | 17178689 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 49.20 | 12151625 | |
| MESH:D008114 | Liver Neoplasms, Experimental | triadimefon | 49.20 | 17178689 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Vanadium | 49.20 | 17174075 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 2.27 | 15213294 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 22.51 | 12815614 | |
| MESH:D008171 | Lung Diseases | Acrolein | 22.51 | 11504702 | |
| MESH:D008171 | Lung Diseases | Ascorbic Acid | 22.51 | 16863852 | |
| MESH:D008171 | Lung Diseases | chromium hexavalent ion | 22.51 | 16775837 | |
| MESH:D008171 | Lung Diseases | Nitrofurantoin | 22.51 | 14966256 9429087 | |
| MESH:D008171 | Lung Diseases | Ozone | 22.51 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 22.51 | 19095001 | |
| MESH:D008171 | Lung Diseases | Vitamin E | 22.51 | 16863852 | |
| MESH:D017563 | Lung Diseases, Interstitial | Benzene | 11.70 | 14698565 | |
| MESH:D017563 | Lung Diseases, Interstitial | Methotrexate | 11.70 | 18516814 | |
| MESH:D017563 | Lung Diseases, Interstitial | Nitrofurantoin | 11.70 | 18516814 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 8.03 | 21114838 | |
| MESH:D055370 | Lung Injury | Nitrofurantoin | 8.03 | 1313237 | |
| MESH:D055370 | Lung Injury | Ozone | 8.03 | 20417186 | |
| MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 65.88 | 14755239 15172992 15893417 17139156 18813816 9255578 16061637 12438228 19931552 18508827 16401635 | |
| MESH:D008175 | Lung Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 65.88 | 11376689 | |
| MESH:D008175 | Lung Neoplasms | Acrylonitrile | 65.88 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | Aflatoxin B1 | 65.88 | 14755239 | |
| MESH:D008175 | Lung Neoplasms | Arsenic | 65.88 | 17306315 19168569 17976673 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 65.88 | 11798837 19825857 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 65.88 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Ascorbic Acid | 65.88 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Azacitidine | 65.88 | 21224363 | |
| MESH:D008175 | Lung Neoplasms | Benzene | 65.88 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 65.88 | 18520028 18816296 20135361 20464547 6695378 18569708 20064080 17053015 20869020 | |
| MESH:D008175 | Lung Neoplasms | Butylated Hydroxytoluene | 65.88 | 19925653 18597497 15390079 16337739 11696405 19359593 11246140 | |
| MESH:D008175 | Lung Neoplasms | chromium hexavalent ion | 65.88 | 16570259 16876463 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 65.88 | 11798837 6189445 17225452 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 65.88 | 19359593 18462866 16243823 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 65.88 | 11195469 15824018 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 65.88 | 21163286 20970405 20512841 6695378 | |
| MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 65.88 | 16061637 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Iron | 65.88 | 16640825 | |
| MESH:D008175 | Lung Neoplasms | Melatonin | 65.88 | 17195641 | |
| MESH:D008175 | Lung Neoplasms | Methylcholanthrene | 65.88 | 9230183 10545420 16271038 17909032 1399818 16337739 15390079 11893704 20970405 6695378 7750092 21163286 20512841 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 65.88 | 7614698 8597069 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 65.88 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Polycyclic Hydrocarbons, Aromatic | 65.88 | 10814675 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 65.88 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 65.88 | 16712894 17077188 17306315 15276417 19931552 | |
| MESH:D008175 | Lung Neoplasms | Styrene | 65.88 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 65.88 | 15713900 19359593 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 65.88 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 65.88 | 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 65.88 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | vanadium pentoxide | 65.88 | 12376484 | |
| MESH:D008175 | Lung Neoplasms | Vehicle Emissions | 65.88 | 9255578 | |
| MESH:D008175 | Lung Neoplasms | Vitamin E | 65.88 | 11062179 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Melatonin | 3.36 | 16373423 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 3.81 | 15166399 | |
| MESH:D008223 | Lymphoma | 9,10-Dimethyl-1,2-benzanthracene | 22.56 | 11376689 | |
| MESH:D008223 | Lymphoma | Benzene | 22.56 | 17119257 17584886 | |
| MESH:D008223 | Lymphoma | Curcumin | 22.56 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 22.56 | 12854902 | |
| MESH:D008223 | Lymphoma | decitabine | 22.56 | 19470736 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 22.56 | 15700306 | |
| MESH:D008223 | Lymphoma | Etoposide | 22.56 | 12854902 12556972 | |
| MESH:D008223 | Lymphoma | Methotrexate | 22.56 | 17352296 | |
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 9.98 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 9.98 | 17088997 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 9.98 | 14737004 | |
| MESH:D017728 | Lymphoma, Large-Cell, Anaplastic | 17-(allylamino)-17-demethoxygeldanamycin | 5.28 | 17157164 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 5.18 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 5.18 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 3.39 | 16173963 | |
| MESH:D008268 | Macular Degeneration | Iron | 3.07 | 16640825 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 4.16 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Acrylonitrile | 17.58 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Benzene | 17.58 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 17.58 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Styrene | 17.58 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 17.58 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 2,4-diaminotoluene | 34.84 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 9,10-Dimethyl-1,2-benzanthracene | 34.84 | 1500032 8985016 11807958 16082771 18840765 12844480 16153821 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Benzene | 34.84 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Butylated Hydroxytoluene | 34.84 | 1500032 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 34.84 | 11807958 11408345 17203775 16891317 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 34.84 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 34.84 | 12929590 14578162 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Ibuprofen | 34.84 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | LY 353381 | 34.84 | 12374698 11731420 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 34.84 | 8985016 11606380 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 34.84 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 34.84 | 16827153 11731420 14580682 19196723 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 34.84 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 34.84 | 12773700 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 8.17 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 8.17 | 19453300 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 2.05 | 17453147 | |
| MESH:D008545 | Melanoma | Carboplatin | 20.23 | 12040289 11712820 16342250 16225601 | |
| MESH:D008545 | Melanoma | Cisplatin | 20.23 | 16248763 18176117 11135225 12374674 12883367 16432458 17023156 12393984 16809738 18505091 18332650 17761969 15577323 | |
| MESH:D008545 | Melanoma | Curcumin | 20.23 | 18462866 17885582 | |
| MESH:D008545 | Melanoma | decitabine | 20.23 | 17785578 16505122 | |
| MESH:D008545 | Melanoma | Dinitrochlorobenzene | 20.23 | 12202904 17334785 | |
| MESH:D008545 | Melanoma | Disulfiram | 20.23 | 15367699 | |
| MESH:D008545 | Melanoma | Fenretinide | 20.23 | 16270382 | |
| MESH:D008545 | Melanoma | resveratrol | 20.23 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 20.23 | 19082730 16487513 | |
| MESH:D008545 | Melanoma | Sulindac | 20.23 | 16642371 | |
| MESH:D008545 | Melanoma | Tamoxifen | 20.23 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Tretinoin | 20.23 | 16752155 | |
| MESH:D008545 | Melanoma | Vitamin K 3 | 20.23 | 19082730 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 7.11 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 7.11 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 10.99 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 10.99 | 10803710 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 10.99 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 5.91 | 17263510 | |
| MESH:D008569 | Memory Disorders | Lead | 5.91 | 17263510 16384672 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 3.11 | 16940565 | |
| MESH:D007706 | Menkes Kinky Hair Syndrome | Copper | 4.54 | 17268249 17109627 | |
| MESH:D008607 | Mental Retardation | Toluene | 3.01 | 9294310 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 3.75 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 3.75 | 15107826 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 3.14 | 17112576 | |
| MESH:D008679 | Metaplasia | Ozone | 3.75 | 10496685 | |
| MESH:D009006 | Monosomy | Azacitidine | 4.72 | 19299654 | |
| MESH:D019957 | Motor Skills Disorders | Toluene | 3.97 | 9294310 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 5.05 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fenretinide | 5.05 | 16274795 | |
| MESH:D052016 | Mucositis | irinotecan | 8.19 | 17159606 | |
| MESH:D052016 | Mucositis | Methotrexate | 8.19 | 17488658 | |
| MESH:D009101 | Multiple Myeloma | marker/mechanism | 16949155 | ||
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 21.28 | 19549372 14977855 19417148 15949261 11468182 | |
| MESH:D009101 | Multiple Myeloma | Azacitidine | 21.28 | 18443271 19549372 | |
| MESH:D009101 | Multiple Myeloma | Benzene | 21.28 | 17119195 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 21.28 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 21.28 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 21.28 | 15867202 16118317 15744524 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 21.28 | 17049120 16490592 17935668 16267019 14749477 17164350 | |
| MESH:D009101 | Multiple Myeloma | S-(dimethylarsino)-glutathione | 21.28 | 19417148 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 4.32 | 17086897 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 8.01 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 8.01 | 17962980 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 2.21 | 16239165 | |
| MESH:D009139 | Musculoskeletal Abnormalities | sodium arsenate | 3.62 | 18186108 | |
| MESH:D009181 | Mycoses | Iron | 4.12 | 16640825 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.32 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 12.89 | 16105982 16882451 | |
| MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 12.89 | 19805378 17596541 18720364 17611569 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 12.89 | 19157545 18608210 19010910 16882708 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 12.89 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 12.89 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 6.90 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 6.90 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 6.90 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 6.90 | 17125593 17188708 16456233 16525036 17015251 16317513 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 12.51 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | Iron | 12.51 | 16604332 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 12.51 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 12.51 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 14.84 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 14.84 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Iron | 14.84 | 16604332 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 14.84 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 14.84 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.43 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 3.14 | 17484760 | |
| MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 14.74 | 18551238 | |
| MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 14.74 | 18551238 7678174 | |
| MESH:D009336 | Necrosis | Melatonin | 14.74 | 12195237 | |
| MESH:D009336 | Necrosis | Trinitrotoluene | 14.74 | 18551238 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 18.99 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | bis(4-hydroxycinnamoyl)methane | 18.99 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 18.99 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | demethoxycurcumin | 18.99 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Disulfiram | 18.99 | 18047805 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 9.51 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 9.51 | 9029167 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Disulfiram | 9.51 | 15367699 | |
| MESH:D009362 | Neoplasm Metastasis | irinotecan | 9.51 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 9.51 | 19393235 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.89 | 19410462 | |
| MESH:D009369 | Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 32.32 | 11544531 | |
| MESH:D009369 | Neoplasms | Acrolein | 32.32 | 17329238 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 32.32 | 11141357 | |
| MESH:D009369 | Neoplasms | Carboplatin | 32.32 | 17925555 18854779 | |
| MESH:D009369 | Neoplasms | Cisplatin | 32.32 | 16773208 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 32.32 | 18854779 | |
| MESH:D009369 | Neoplasms | decitabine | 32.32 | 17925555 19116145 19470736 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 32.32 | 15313581 | |
| MESH:D009369 | Neoplasms | Disulfiram | 32.32 | 17079463 | |
| MESH:D009369 | Neoplasms | Fenretinide | 32.32 | 17353921 15958647 | |
| MESH:D009369 | Neoplasms | Oleanolic Acid | 32.32 | 8847885 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 32.32 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 32.32 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 32.32 | 11559025 | |
| MESH:D009369 | Neoplasms | Tretinoin | 32.32 | 16946489 16594593 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 4.98 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 4.98 | 20056578 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 6.40 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 6.40 | 19189210 19196722 19200415 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 13.61 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Copper | 13.61 | 17308104 | |
| MESH:D009389 | Neovascularization, Pathologic | Disulfiram | 13.61 | 15367699 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 13.61 | 17289903 | |
| MESH:D009393 | Nephritis | Acrolein | 4.93 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 14.42 | 15464296 | |
| MESH:D009395 | Nephritis, Interstitial | Ibuprofen | 14.42 | 6375363 | |
| MESH:D009395 | Nephritis, Interstitial | Nitrofurantoin | 14.42 | 19214031 | |
| MESH:D009395 | Nephritis, Interstitial | Tetracycline | 14.42 | 9884423 | |
| MESH:D009404 | Nephrotic Syndrome | Iron | 3.34 | 17178036 | |
| MESH:D009410 | Nerve Degeneration | Ibuprofen | 5.12 | 10961664 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 5.12 | 16893418 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 17.45 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 17.45 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 17.45 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 17.45 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 17.45 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.27 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 18.63 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 18.63 | 16620997 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 18.63 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Benzene | 18.63 | 15643154 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenate | 18.63 | 10525206 18186108 11749123 19446573 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 18.63 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 18.63 | 9142499 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 3.87 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 6.29 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 6.29 | 16115947 15176712 8761367 | |
| MESH:D009447 | Neuroblastoma | irinotecan | 6.29 | 8761367 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 18.00 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 18.00 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 18.00 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Iron | 18.00 | 16604332 17296847 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 18.00 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 18.00 | 17266991 16850258 | |
| MESH:D017599 | Neuroectodermal Tumors | Carboplatin | 16.53 | 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 16.53 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 16.53 | 12837982 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | irinotecan | 16.53 | 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 10.58 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 10.58 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 10.58 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.76 | 20387270 | |
| MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 4.34 | 16303764 | |
| MESH:D020258 | Neurotoxicity Syndromes | Disulfiram | 3.63 | 11005259 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 3.10 | 8291058 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | Clofibrate | 7.73 | 9802331 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | perfluorooctanoic acid | 7.73 | 9802331 | |
| MESH:D009669 | Nose Neoplasms | chromium hexavalent ion | 3.84 | 16876463 | |
| MESH:D009765 | Obesity | marker/mechanism | 17405841 | ||
| MESH:D009765 | Obesity | Ascorbic Acid | 7.60 | 17217161 | |
| MESH:D009765 | Obesity | Curcumin | 7.60 | 19297423 | |
| MESH:D009765 | Obesity | Dietary Fats | 7.60 | 17217161 16723640 20518802 20132043 18457598 18674790 19632207 11836018 21332399 | |
| MESH:D009765 | Obesity | pirinixic acid | 7.60 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 7.60 | 19056576 20132043 | |
| MESH:D009784 | Occupational Diseases | marker/mechanism | 15727169 17178637 15576619 | ||
| MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 15.72 | 12819281 16049721 | |
| MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 15.72 | 16049721 | |
| MESH:D009784 | Occupational Diseases | 4-amino-2,6-dinitrotoluene | 15.72 | 14694615 | |
| MESH:D009784 | Occupational Diseases | Benzene | 15.72 | 15612468 15935809 15727169 15576619 15913788 17178637 16737584 17479406 17119257 | |
| MESH:D009784 | Occupational Diseases | Trinitrotoluene | 15.72 | 12819281 17852074 14694615 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 3.40 | 16517039 | |
| MESH:D010003 | Osteoarthritis | Diclofenac | 9.88 | 18287210 | |
| MESH:D010003 | Osteoarthritis | Ibuprofen | 9.88 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Iron | 9.88 | 16640825 | |
| MESH:D010003 | Osteoarthritis | rofecoxib | 9.88 | 16690336 | |
| MESH:D010018 | Osteomalacia | Phenobarbital | 3.04 | 17016548 | |
| MESH:D010024 | Osteoporosis | Curcumin | 8.82 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 8.82 | 19401787 | |
| MESH:D010024 | Osteoporosis | Iron | 8.82 | 16648989 16640825 | |
| MESH:D010024 | Osteoporosis | Isoflavones | 8.82 | 16562857 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 9.68 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 9.68 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 9.68 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Disulfiram | 4.03 | 18047805 | |
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 39.31 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 39.31 | 16891317 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 39.31 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 39.31 | 16624393 19769630 12452020 | |
| MESH:D010051 | Ovarian Neoplasms | Benzene | 39.31 | 12562636 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 39.31 | 17225452 15464296 19769630 6897625 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 39.31 | 19020741 18462866 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 39.31 | 19331143 19259094 | |
| MESH:D010051 | Ovarian Neoplasms | Disulfiram | 39.31 | 17026967 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 39.31 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Fenretinide | 39.31 | 16133793 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 39.31 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 39.31 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 39.31 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 39.31 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 39.31 | 16936753 | |
| MESH:D010146 | Pain | Acetaminophen | 14.78 | 16870215 | |
| MESH:D010146 | Pain | Cyclophosphamide | 14.78 | 18093676 12161096 | |
| MESH:D010146 | Pain | Diclofenac | 14.78 | 13679232 | |
| MESH:D010146 | Pain | Ibuprofen | 14.78 | 3291741 | |
| MESH:D010146 | Pain | Phenol | 14.78 | 17610455 | |
| MESH:D010146 | Pain | Sulindac | 14.78 | 3291741 | |
| MESH:D010146 | Pain | Tretinoin | 14.78 | 16870215 | |
| MESH:D010149 | Pain, Postoperative | Ibuprofen | 7.29 | 16678543 | |
| MESH:D010149 | Pain, Postoperative | rofecoxib | 7.29 | 16678543 18165598 | |
| MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 42.26 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 42.26 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 42.26 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 42.26 | 17440100 19196508 19401701 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 42.26 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 42.26 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 42.26 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Etoposide | 42.26 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 42.26 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Ibuprofen | 42.26 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Mitomycin | 42.26 | 15113037 | |
| MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 42.26 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 42.26 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 42.26 | 16820089 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 42.26 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 42.26 | 15976015 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.43 | 11578682 | |
| MESH:D010212 | Papilloma | 9,10-Dimethyl-1,2-benzanthracene | 15.57 | 16517061 15173996 17234724 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 15.57 | 12065085 | |
| MESH:D010212 | Papilloma | Iron | 15.57 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 15.57 | 15173996 16517061 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 15.57 | 18922899 12065085 18404319 8330346 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.90 | 19927285 | |
| MESH:D020447 | Parasomnias | Iron | 4.66 | 17352947 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 4.57 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Iron | 4.57 | 16640825 16563566 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 4.57 | 15824117 15451049 16510128 12911755 11124998 16140633 11445065 11181820 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 3.13 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Melatonin | 3.85 | 15574749 | |
| MESH:D010382 | Peliosis Hepatis | 1-Naphthylisothiocyanate | 9.31 | 20133375 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 9.31 | 12520081 | |
| MESH:D010391 | Pemphigoid, Bullous | Tetracycline | 4.08 | 11026799 | |
| MESH:D010392 | Pemphigus | Phenol | 5.09 | 17163923 16522979 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 5.84 | 16093927 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 5.84 | 15464296 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 8.68 | 6392382 15371236 16905509 | |
| MESH:D016491 | Peripheral Vascular Diseases | Cadmium | 8.68 | 15687053 | |
| MESH:D010538 | Peritonitis | Melatonin | 6.28 | 15707874 | |
| MESH:D010538 | Peritonitis | Ozone | 6.28 | 16369182 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 4.39 | 11550810 | |
| MESH:D010864 | Pilonidal Sinus | Phenol | 5.09 | 19655223 15622588 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 9.58 | 14722030 | |
| MESH:D010900 | Pituitary Diseases | Iron | 9.58 | 16604332 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 3.36 | 15687265 16977796 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.53 | 15087411 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 3.99 | 17638057 | |
| MESH:D011014 | Pneumonia | Butylated Hydroxytoluene | 15.80 | 11893704 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 15.80 | 11605937 12224865 | |
| MESH:D011014 | Pneumonia | Ozone | 15.80 | 18929643 18007984 18381685 | |
| MESH:D011014 | Pneumonia | Paraquat | 15.80 | 12504350 | |
| MESH:D011041 | Poisoning | Iron | 5.25 | 16604332 | |
| MESH:D011041 | Poisoning | Phenol | 5.25 | 8825745 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Flutamide | 3.78 | 15356085 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Iron | 6.77 | 16640825 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 6.77 | 18163543 | |
| MESH:D011164 | Porphyrias | 1,2,4-trichlorobenzene | 5.45 | 6636202 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 8.54 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Phenobarbital | 8.54 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 8.54 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | marker/mechanism | 17332311 | ||
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 4.65 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 4.65 | 21297632 | |
| MESH:D011225 | Pre-Eclampsia | Iron | 5.79 | 16640825 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 5.79 | 17114810 | |
| MESH:D011248 | Pregnancy Complications | Nitrofurantoin | 4.50 | 19789166 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 16.78 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Lead | 16.78 | 16384672 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | perfluorooctanoic acid | 16.78 | 17132714 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 16.78 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 16.78 | 11118676 11399792 11896295 11222880 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 3.42 | 17616702 | |
| MESH:D017096 | Prion Diseases | Tetracycline | 4.08 | 10903871 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 2.65 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 17507624 | ||
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 16.61 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 16.61 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Azacitidine | 16.61 | 18324645 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 16.61 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | Cadmium | 16.61 | 17075824 | |
| MESH:D011471 | Prostatic Neoplasms | Copper | 16.61 | 17079463 17308104 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 16.61 | 18226269 15129424 11398177 18769126 18156803 12497104 10851300 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 16.61 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 16.61 | 15046698 15846301 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Disulfiram | 16.61 | 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 16.61 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Etoposide | 16.61 | 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | Fenretinide | 16.61 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | Flurbiprofen | 16.61 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | Flutamide | 16.61 | 3169114 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 16.61 | 15378649 16925846 15256057 | |
| MESH:D011471 | Prostatic Neoplasms | Ibuprofen | 16.61 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | Isoflavones | 16.61 | 17219775 17571952 17374662 16365062 | |
| MESH:D011471 | Prostatic Neoplasms | methylselenic acid | 16.61 | 16205645 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 16.61 | 14666653 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 16.61 | 14715546 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 16.61 | 17675339 17636462 17804756 15767336 16731767 17718901 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 16.61 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 16.61 | 18760546 | |
| MESH:D011471 | Prostatic Neoplasms | sulindac sulfone | 16.61 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 16.61 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | Vitamin E | 16.61 | 15084515 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 16.61 | 16606632 16517595 16700911 12429649 | |
| MESH:D011507 | Proteinuria | Arsenic | 8.39 | 21343184 | |
| MESH:D011507 | Proteinuria | Ibuprofen | 8.39 | 6375363 | |
| MESH:D011507 | Proteinuria | Tretinoin | 8.39 | 16636307 | |
| MESH:D011528 | Protozoan Infections | Iron | 4.66 | 16640825 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 2.02 | 15861022 16919318 | |
| MESH:D019310 | Pseudolymphoma | Phenobarbital | 3.15 | 12752131 | |
| MESH:D011565 | Psoriasis | Methotrexate | 2.78 | 17410198 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.46 | 16723453 | |
| MESH:D011654 | Pulmonary Edema | Nitrofurantoin | 4.46 | 9429087 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.31 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | Ascorbic Acid | 3.98 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 5.11 | 16636934 | |
| MESH:D011658 | Pulmonary Fibrosis | Nitrofurantoin | 5.11 | 1551546 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 5.11 | 17997886 16324872 | |
| MESH:D000608 | Renal Aminoacidurias | Mercuric Chloride | 4.75 | 2918855 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 9.90 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 9.90 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Methotrexate | 9.90 | 17352296 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.22 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 3.65 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 3.65 | 17058453 17520802 15827377 16314181 16317513 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 11.51 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 11.51 | 10666014 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 11.51 | 11700416 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 11.51 | 11700416 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 2.72 | 10835634 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 5.88 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Vehicle Emissions | 5.88 | 18950799 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.55 | 18990726 | |
| MESH:D012148 | Restless Legs Syndrome | Iron | 3.43 | 16930377 | |
| MESH:D012162 | Retinal Degeneration | Fenretinide | 8.70 | 16303925 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 8.70 | 16458197 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 8.70 | 16584753 | |
| MESH:D012174 | Retinitis Pigmentosa | Ascorbic Acid | 4.17 | 16849425 | |
| MESH:D012174 | Retinitis Pigmentosa | Thioctic Acid | 4.17 | 16849425 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 6.76 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 6.76 | 16116481 16283617 | |
| MESH:D012509 | Sarcoma | Curcumin | 2.93 | 18462866 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 14.30 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 14.30 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 14.30 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Etoposide | 14.30 | 14601052 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.19 | 16862918 | |
| MESH:D012559 | Schizophrenia | Copper | 2.88 | 16842975 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 3.56 | 16636934 | |
| MESH:D012640 | Seizures | 2,4-dinitrotoluene | 10.08 | 18551238 | |
| MESH:D012640 | Seizures | 2,6-dinitrotoluene | 10.08 | 18551238 | |
| MESH:D012640 | Seizures | Acrylonitrile | 10.08 | 20127315 | |
| MESH:D012640 | Seizures | Phenobarbital | 10.08 | 16876388 3137016 11442880 4039156 | |
| MESH:D012640 | Seizures | Toluene | 10.08 | 6431079 9294310 | |
| MESH:D012640 | Seizures | Trinitrotoluene | 10.08 | 18551238 | |
| MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.48 | 6407741 | |
| MESH:D018805 | Sepsis | Curcumin | 2.92 | 18389075 | |
| MESH:D012871 | Skin Diseases | Arsenic | 6.21 | 17050553 16759981 18709164 16702368 15952646 19834688 17938729 6392382 17548696 17453740 16353154 | |
| MESH:D012871 | Skin Diseases | Ascorbic Acid | 6.21 | 18709164 | |
| MESH:D012871 | Skin Diseases | monomethylarsonous acid | 6.21 | 17431481 | |
| MESH:D012871 | Skin Diseases | Vitamin E | 6.21 | 18709164 | |
| MESH:D012878 | Skin Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 33.04 | 8985016 15173996 16517061 11376689 | |
| MESH:D012878 | Skin Neoplasms | Arsenic | 33.04 | 17050553 17029826 15504454 17976673 19538983 16251483 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 33.04 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | Fenretinide | 33.04 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 33.04 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Iron | 33.04 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 33.04 | 16517061 15173996 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 33.04 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 33.04 | 18572023 19524636 | |
| MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 33.04 | 8532709 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 33.04 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 33.04 | 8985016 12065085 18404319 8330346 11807781 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 33.04 | 16467112 | |
| MESH:D012893 | Sleep Disorders | Melatonin | 4.15 | 16919138 16897403 18182647 | |
| MESH:D020178 | Sleep Disorders, Circadian Rhythm | Melatonin | 5.28 | 18078449 19452292 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Melatonin | 3.94 | 18078449 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 3.99 | 15464296 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 18.32 | 16709447 16002989 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 18.32 | 16709447 | |
| MESH:D013088 | Spermatocele | Phenol | 18.32 | 18646496 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 18.32 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 4.18 | 16517039 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 2.72 | 19457130 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 2.67 | 12854658 | |
| MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 3.92 | 12587719 | |
| MESH:D013163 | Splenomegaly | Trinitrotoluene | 3.89 | 15817613 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 3.02 | 15472012 | |
| MESH:D013274 | Stomach Neoplasms | Acrylonitrile | 11.28 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 11.28 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzene | 11.28 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 11.28 | 2093021 20155912 | |
| MESH:D013274 | Stomach Neoplasms | Butylated Hydroxyanisole | 11.28 | 3581430 1399818 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 11.28 | 18396642 17522103 15958060 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 11.28 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 11.28 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 11.28 | 16033868 | |
| MESH:D013274 | Stomach Neoplasms | irinotecan | 11.28 | 15723263 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 11.28 | 17261132 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 18.87 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Ascorbic Acid | 18.87 | 18726076 | |
| MESH:D013276 | Stomach Ulcer | bis(4-hydroxycinnamoyl)methane | 18.87 | 19188055 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 18.87 | 19188055 16631530 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 18.87 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Melatonin | 18.87 | 12500499 16150113 11523592 | |
| MESH:D013276 | Stomach Ulcer | pimagedine | 18.87 | 18209962 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 18.87 | 17135157 18237397 18193104 15255614 12787963 | |
| MESH:D020521 | Stroke | Acrolein | 8.02 | 16269634 | |
| MESH:D020521 | Stroke | Ascorbic Acid | 8.02 | 16403987 16517955 | |
| MESH:D020521 | Stroke | Vitamin E | 8.02 | 16517955 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.26 | 16321402 | |
| MESH:D013398 | Sudden Infant Death | Iron | 4.12 | 16640825 | |
| MESH:D015173 | Supratentorial Neoplasms | Carboplatin | 8.07 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 8.07 | 12837982 | |
| MESH:D013576 | Syndactyly | Methotrexate | 3.75 | 9562676 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 4.13 | 17997062 | |
| MESH:D013733 | Testicular Diseases | phenethyl isothiocyanate | 9.98 | 15864552 | |
| MESH:D013733 | Testicular Diseases | pyrazole | 9.98 | 6499806 | |
| MESH:D013733 | Testicular Diseases | Toluene | 9.98 | 10514026 10048760 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.37 | 15464296 17225452 | |
| MESH:D013921 | Thrombocytopenia | 1-Naphthylisothiocyanate | 6.03 | 20133375 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 6.03 | 15821434 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.36 | 11994571 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 1.99 | 15669648 | |
| MESH:D013953 | Thymus Neoplasms | Benzene | 3.63 | 10850423 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.55 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 17.06 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Butyrates | 17.06 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 17.06 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 17.06 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 17.06 | 1399818 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 17.06 | 16026305 17045167 | |
| MESH:D013964 | Thyroid Neoplasms | triadimefon | 17.06 | 17178689 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 3.33 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | 4-Nitroquinoline-1-oxide | 13.92 | 16543248 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 13.92 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 13.92 | 16051514 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 13.92 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 2.66 | 15213294 | |
| MESH:D014202 | Tremor | Lead | 4.16 | 21145352 | |
| MESH:D014277 | Trigeminal Neuralgia | Phenol | 5.09 | 16527771 10223447 | |
| MESH:D014376 | Tuberculosis | Iron | 4.82 | 16597321 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 4.82 | 16040207 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 53.46 | 16049721 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 53.46 | 16049721 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-nitroanisole | 53.46 | 14729594 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 53.46 | 19322015 19429237 17306315 17976673 11144890 18640142 15987713 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 53.46 | 12973940 20435036 12845720 11780464 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 53.46 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Butylated Hydroxyanisole | 53.46 | 1399818 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cacodylic Acid | 53.46 | 15537745 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 53.46 | 12973940 15464296 17225452 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 53.46 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 53.46 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 53.46 | 17616700 19087683 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 53.46 | 17306315 16452187 16712894 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 53.46 | 16720286 | |
| MESH:D001749 | Urinary Bladder Neoplasms | monomethylarsonous acid | 53.46 | 20375083 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Nitrofurantoin | 53.46 | 15028437 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 53.46 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 53.46 | 11723127 16452187 16712894 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 53.46 | 8653321 17572228 16712894 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Vehicle Emissions | 53.46 | 11144890 | |
| MESH:D014552 | Urinary Tract Infections | Nitrofurantoin | 5.24 | 1551546 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.93 | 18462866 | |
| MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 7.58 | 10091137 | |
| MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 7.58 | 10091137 | |
| MESH:D014581 | Urticaria | Acetaminophen | 1.77 | 10982225 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 26.28 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 26.28 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 26.28 | 16154183 | |
| MESH:D002583 | Uterine Cervical Neoplasms | indole-3-carbinol | 26.28 | 16082211 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 26.28 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 26.28 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 26.28 | 16129372 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 3.81 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | Benzene | 21.14 | 12562636 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 21.14 | 15809267 16690809 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 21.14 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 21.14 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 21.14 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | sulindac sulfide | 21.14 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 8.36 | 17785578 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 8.36 | 16752155 | |
| MESH:D014605 | Uveitis | Dexamethasone | 3.47 | 1336536 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 6.76 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 6.76 | 16002989 16513791 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 7.45 | 17056641 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 7.45 | 17056641 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.24 | 12125929 | |
| MESH:D020301 | Vasospasm, Intracranial | Ibuprofen | 3.87 | 19057314 | |
| MESH:D014689 | Venous Insufficiency | coumarin | 4.42 | 12708602 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.31 | 15869587 14671159 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 6.23 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 6.23 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 3.98 | 18097624 | |
| MESH:D014820 | Vitiligo | Tretinoin | 2.78 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 3.38 | 11897121 | |
| MESH:D014860 | Warts | Phenol | 4.74 | 19122958 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.89 | 15886252 | |
| MESH:D015430 | Weight Gain | Dietary Fats | 2.56 | 16723640 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.77 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 3.13 | 19894650 20213670 |
| Pathway ID | Pathway Name |
|---|---|
| REACT:13 | Metabolism of amino acids and derivatives |
| No data |
| Releated disease ID | Related disease Name |
|---|---|
| PA447295 | Malignant tumor of peritoneum |
| PA444760 | Leukemia, Myeloid, Acute |
| PA444761 | Leukemia, Myeloid |
| PA446827 | Hematologic Neoplasms |
| PA445988 | Urinary Calculi |
| PA445018 | Cardiomyopathies |
| PA443937 | Drug Toxicity |
| PA444370 | Heart Failure |
| PA164925725 | Toxic liver disease |
| Releated drug ID | Related drug Name |
|---|---|
| PA165291924 | 7-deoxydoxorubicinone |
| PA165291923 | doxorubicin seminquinone radical |
| PA451141 | propofol |
| PA450358 | menadione |
| PA449412 | doxorubicin |
| PA449014 | cisplatin |
| PA449298 | dicumarol |
| PA450524 | mitomycin |
| PA449552 | etoposide |
| PA130620651 | anthracyclines and related substances |
| PA449476 | epirubicin |
| PA452604 | xenobiotics |
| PA451991 | 1-methyloxy-4-sulfone-benzene |
| PA450961 | phytonadione |
| PA164712471 | Antimycobacterials |
| PA164712708 | Drugs For Treatment Of Tuberculosis |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB00170 | - | Menadione | Dietary supplement;Micronutrient;Antifibrinolytic Agents;Vitamins/minerals;Vitamins |
| DB00266 | antagonist | Dicumarol | Anticoagulants;Enzyme Inhibitors;Uncoupling Agents |
| DB01927 | - | Duroquinone | |
| DB02395 | - | 3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol | |
| DB02400 | - | 5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione | |
| DB02633 | - | Cibacron Blue | |
| DB03147 | - | Flavin-Adenine Dinucleotide | |
| DB03626 | - | 5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione | |
| DB04090 | - | 2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione | |
| DB04392 | - | Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone] | |
| DB07385 | - | 3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE |
| No data |
| No data |
| No data |